Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AK7	"CFAP75, FAP75, FLJ32864"	ENSG00000140057	"Adenylate kinase 7"	Q96M32	14	96392128-96489427	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.3"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003543	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003543: AB_1078117"	"unprognostic (4.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (3.18e-4)"	"unprognostic (4.98e-5)"	"unprognostic (8.41e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.25e-3)"	0.7	2.6	2.0	0.6	3.1	1.5	1.4	1.1	1.7	1.7	13.2	2.1	1.9	2.1	3.9	1.5	24.3	2.6	0.7	2.2	5.2	4.5	1.6	4.2	0.6	6.9	9.4	0.4	2.2	6.9	5.1	0.5	5.6	0.9	1.6	3.0	1.0	1.3	0.3	6.1	1.2	1.1	4.4	3.3	2.8	7.6	5.0	0.5	2.7	0.0	0.4	0.5	1.0	4.2	0.2	4.9	2.0	1.5	0.8	2.6	17.0	0.3	0.6	0.3	0.3	0.5	15.1	0.4	0.3	0.0	0.3	1.9	4.7	0.2	0.1	2.2	0.4	0.4	2.4	0.2	0.8	0.1	0.3	0.2	0.6	2.5	0.1	0.8	0.2	1.4	0.2	0.3	0.3	49.5	0.3	0.3	0.8	2.2	1.0	35.2	0.3	0.4	7.6	0.3	3.1	6.7	1.9	0.6	0.1	1.8	4.2	0.2	0.1	0.4	0.2	0.6	0.2	0.6	2.3	0.2	0.2	0.0	0.7	9.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.1	2.0	3.1	1.1	1.7	2.2	5.2	6.9	9.4	5.6	4.4	5.0	4.2	1.6	6.4	4.1	0.7	0.8	1.8	0.9	3.6	1.8	0.2	0.9	0.3	0.4	4.3	12.3	7.3	2.1	0.7	0.1	1.4	3.9	3.2	18.7	97.9	1.7	1.9	1.2	6.9	2.0	1.1	1.7	0.8	5.1	11.6	0.0	0.1	0.7	2.4	0.2	0.0	2.4	0.3	4.1	0.3	0.4	4.1	0.0	0.5	1.8	0.0	0.0	0.6	0.0	0.5	3.7	0.5	0.1	0.0	0.0	0.5	1.0	3.4	137.1	1.8	0.0	0.4	1.6	25.4	9.1	0.7	3.0	2.9	0.2	1.5	1.2	0.6
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AMH	MIS	ENSG00000104899	"Anti-Mullerian hormone"	P03971	19	2249309-2252073	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Differentiation, Gonadal differentiation"	"Growth factor"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 3.9;testis: 10.5"	"Cell type enriched"	"Detected in many"	61	"Granulosa cells: 1567.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 16.9;NTERA-2: 6.4;REH: 7.0;SH-SY5Y: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066973			Approved	Vesicles,Aggresome	"Secreted to blood"	NA	NA	1580000	280000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Aggresome"		"HPA066973: AB_2732754"	"unprognostic (8.10e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (8.73e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.34e-2)"	"unprognostic (8.73e-8)"	"unprognostic (4.64e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.76e-1)"	0.2	0.2	0.7	0.0	1.2	0.0	0.2	1.2	1.3	0.4	0.0	0.8	0.0	0.3	0.0	0.3	0.4	0.0	0.2	0.2	0.4	0.5	0.3	0.3	0.0	0.4	0.5	1.1	1.2	0.0	3.9	0.0	0.4	0.5	0.0	0.0	0.2	0.0	1.5	0.2	0.4	0.0	0.6	0.2	0.2	10.5	0.6	0.0	0.3	0.0	0.0	0.2	0.3	0.4	2.8	0.2	0.1	0.4	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.1	0.2	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	16.9	0.1	0.8	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.4	0.0	0.5	0.1	1.3	6.4	0.0	1.5	7.0	1.4	0.9	0.0	0.2	0.4	7.7	0.1	0.0	1.7	0.0	0.8	0.0	0.7	0.6	1.3	0.9	2.5	4.7	3.7	0.8	0.3	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	1.2	1.3	0.2	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.3	0.0	0.0	2.0	0.0	0.1	0.2	0.1	0.6	12.1	1.6	2.2	1.1	1.5	0.0	0.0	2.1	0.3	0.4	1.1	0.0	0.3	2.0	0.7	0.8	0.5	1.2	0.4	1.6	0.2	0.3	0.4	0.0	1.5	0.0	1567.5	0.7	0.3	0.1	8.4	11.5	1.0	0.0	0.0	0.0	9.2	1.5	2.3	0.0	1.9	0.1	6.3	0.0	1.0	2.2	0.0	0.0	0.4	0.1	0.1	0.9	0.2	0.1	2.3	0.0	9.2	25.6	8.1	0.6	0.7	0.1	0.0	0.4	0.0	0.8	0.2
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	5.3	3.8	3.8	3.9	7.8	8.8	7.0	0.9	6.8	6.6	31.8	2.9	1.8	7.5	7.6	3.4	20.4	5.2	9.3	3.0	2.3	3.6	2.6	8.6	4.2	2.7	5.9	5.4	2.4	9.4	6.7	6.9	1.2	3.9	4.6	26.7	3.4	4.7	4.0	5.2	3.4	4.1	1.1	5.9	5.0	33.4	7.6	3.8	10.6	1.3	4.2	2.4	2.7	3.6	3.5	2.1	10.1	6.5	4.9	5.9	2.2	2.1	2.9	5.3	7.0	3.2	3.0	5.5	2.6	3.4	8.1	3.0	5.6	4.2	9.1	1.5	4.9	5.1	5.2	3.4	2.6	8.0	2.2	6.8	5.8	6.1	1.7	7.1	5.0	16.6	2.2	8.4	5.5	2.7	7.0	7.3	3.2	3.4	2.6	7.8	8.3	4.3	4.9	4.1	14.0	5.2	7.3	1.8	5.1	5.6	3.7	4.1	2.5	4.4	2.3	3.8	2.9	3.8	5.5	4.7	7.6	5.5	5.6	3.7	2.1	0.6	2.0	3.0	1.8	0.8	1.5	2.2	1.7	1.9	0.9	2.2	6.0	2.9	2.4	2.8	4.7	1.0	3.8	7.8	0.9	6.8	3.0	2.3	2.7	5.9	1.2	1.1	7.6	3.6	2.0	9.6	3.7	80.0	3.4	1.0	1.1	1.9	0.6	2.0	1.2	1.5	6.8	1.5	10.9	0.0	0.0	1.5	2.9	0.3	0.0	1.2	117.7	33.0	2.7	2.2	1.8	2.1	86.1	1.0	2.1	3.0	1.5	1.8	0.0	2.8	0.7	0.3	3.9	1.7	69.3	0.4	4.1	4.4	0.4	145.3	6.8	3.1	5.4	11.2	0.5	1.7	3.1	35.7	24.4	0.7	0.0	10.1	5.9	0.6	0.4	1.8	61.8	4.9	0.0	4.2	4.2	41.5	6.3	1.9	1.4	0.5	5.1	2.5	0.6	0.7
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.2;Spermatocytes: 116.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	1.2	1.1	3.5	1.3	3.7	1.4	2.0	3.8	6.3	0.7	3.0	1.0	0.2	1.3	1.8	1.0	1.1	1.4	1.9	3.5	3.5	1.5	2.7	1.1	3.4	3.7	3.6	0.5	0.9	0.6	1.4	1.9	3.9	0.9	1.3	1.1	0.8	1.4	1.9	1.2	0.8	1.1	3.8	5.0	0.8	46.9	3.7	1.2	1.2	0.5	2.2	1.4	0.8	4.3	0.3	0.1	0.9	0.4	0.3	0.9	0.5	1.7	0.8	1.2	4.4	1.3	0.2	0.1	0.2	0.6	1.0	0.0	0.0	0.9	0.8	0.0	4.9	0.2	0.4	0.0	1.4	0.0	0.3	1.2	0.9	0.9	0.7	1.5	0.8	0.5	0.2	0.0	1.6	0.0	1.5	0.9	38.4	0.2	1.0	0.1	0.3	0.8	0.9	1.7	1.9	0.6	0.0	0.3	0.2	0.1	0.1	1.8	0.4	0.3	5.1	0.4	1.0	1.9	2.7	0.8	1.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.5	3.7	3.8	6.3	3.5	3.5	3.7	3.6	3.9	3.8	3.7	4.3	1.9	0.0	0.5	0.7	0.1	1.1	0.8	0.9	0.0	2.4	1.2	3.8	1.2	0.0	2.5	1.8	0.0	0.4	0.9	0.7	1.9	2.1	150.2	0.8	0.4	0.8	1.8	0.4	1.3	1.0	0.9	1.0	0.0	0.6	0.0	0.5	1.8	0.6	4.1	0.0	1.3	0.3	0.0	2.6	0.8	28.9	1.5	1.2	5.4	0.0	1.0	1.8	1.0	0.0	0.9	1.3	1.4	0.4	0.6	1.3	0.0	0.5	2.7	1.0	6.6	0.4	0.7	116.8	22.9	0.5	1.1	0.3	0.9	0.5	0.4	1.6
BMP15	GDF9B	ENSG00000130385	"Bone morphogenetic protein 15"	O95972	X	50910735-50916641	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRDT	"BRD6, CT9"	ENSG00000137948	"Bromodomain testis associated"	Q58F21	1	91949343-92014426	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"testis: 131.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1313.5;Spermatocytes: 561.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	30	"BEWO: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB012237	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB012237: AB_304756"	"unprognostic (5.00e-2)"	"unprognostic (2.86e-1)"		"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"		"unprognostic (5.25e-2)"		"unprognostic (2.53e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.22e-13)"	"unprognostic (2.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.00e-3)"	0.0	0.0	0.3	0.5	0.5	2.7	0.3	0.8	0.7	0.1	0.5	0.1	0.4	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.2	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.1	131.4	0.6	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	21.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	0.3	0.2	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.3	0.1	0.2	0.1	0.2	0.3	0.5	0.8	0.7	0.5	0.3	0.5	0.1	0.4	0.1	0.6	0.9	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.6	0.0	0.0	0.0	0.0	38.0	1.7	0.0	0.0	0.0	1313.5	0.0	0.0	1.8	0.0	0.0	1.2	0.0	22.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	0.0	228.7	7.8	0.8	0.0	0.0	0.0	0.0	1.0	1.0	0.3	0.0	0.0	6.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	561.9	19.9	0.0	0.0	19.4	1.1	0.1	0.0	0.1
BTG4	"APRO3, PC3B"	ENSG00000137707	"BTG anti-proliferation factor 4"	Q9NY30	11	111467526-111512354	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 26.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 61.3;Late spermatids: 80.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057157			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum, Golgi apparatus"		"HPA057157: AB_2683354"		"unprognostic (1.58e-1)"		"unprognostic (2.68e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.80e-4)"		"unprognostic (1.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.39e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	5.2	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	26.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.2	3.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.2	3.1	1.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	1.0	0.5	0.4	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	80.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	10.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 66.0;Excitatory neurons: 101.2;Inhibitory neurons: 73.8;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038932, HPA038933"	Approved		Approved	Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA038932: AB_2676275, HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	4.0	10.8	5.9	5.9	6.5	5.5	11.1	14.3	8.3	8.8	1.9	9.4	9.0	4.1	14.0	23.8	5.5	2.9	5.9	5.8	5.7	24.6	3.1	6.0	6.8	1.8	2.5	4.0	5.9	10.1	12.2	3.3	3.2	13.8	9.3	12.2	14.4	7.0	1.2	41.0	14.2	4.4	0.6	9.9	5.6	23.8	5.6	13.0	4.2	1.4	15.0	5.0	13.4	3.9	16.1	8.7	17.1	11.7	0.9	5.3	3.2	6.8	7.9	7.8	9.8	28.7	19.5	26.4	3.8	5.8	5.2	28.8	7.8	9.8	7.7	6.9	4.5	4.7	12.0	7.3	2.1	3.2	4.7	1.4	35.0	6.1	11.0	11.9	25.2	9.6	7.7	10.0	4.7	17.9	10.8	9.7	26.9	46.4	11.6	6.5	8.1	20.4	33.6	5.8	12.8	12.6	11.2	30.0	24.2	15.1	21.3	2.0	11.7	5.5	9.9	6.0	9.9	7.2	16.2	19.1	6.2	5.5	6.9	2.2	0.8	3.0	1.8	0.4	3.6	10.7	3.3	2.6	0.5	7.4	3.5	3.0	1.6	1.5	0.9	9.1	4.1	0.7	5.9	6.5	14.3	8.3	5.8	5.7	1.8	2.5	3.2	0.6	5.6	3.9	2.8	19.2	3.6	9.8	17.0	11.6	3.2	11.9	4.6	3.6	9.4	7.6	0.5	4.3	8.0	35.0	18.8	1.7	6.0	10.7	9.8	17.0	66.0	5.0	2.1	3.0	13.8	5.7	101.2	11.7	2.3	2.5	5.6	4.4	4.5	3.2	2.2	2.7	3.3	0.0	73.8	12.4	14.2	1.0	5.2	125.5	2.5	1.3	3.6	14.0	4.3	2.0	8.2	9.5	8.5	14.6	12.1	0.4	43.6	2.8	46.2	4.1	4.8	8.7	6.6	2.3	3.0	22.0	22.9	20.4	20.0	1.5	5.9	0.8	10.3	3.2
CATSPER1	CATSPER	ENSG00000175294	"Cation channel sperm associated 1"	Q8NEC5	11	66016752-66026479	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 17.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"				"unprognostic (2.21e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-8)"	"unprognostic (8.79e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.3	0.0	4.4	0.0	4.0	0.8	1.4	0.0	0.0	0.8	0.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	1.1	2.2	0.1	0.2	0.0	0.0	0.0	0.8	0.3	0.6	16.9	5.8	0.1	0.2	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.6	3.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	9.6	0.0	0.0	0.4	44.0	0.1	0.1	0.4	0.0	0.8	0.1	0.7	6.0	0.2	0.0	0.0	99.6	0.0	1.4	0.1	19.9	0.0	0.2	0.0	0.0	17.0	12.2	4.3	0.9	15.4	1.8	0.0	27.3	0.0	42.2	0.5	0.0	3.7	0.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	1.9	1.2	0.0	0.3	0.4	4.5	0.0	0.0	0.3
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.4	0.3	1.1	0.7	0.9	2.2	1.2	0.8	0.9	1.3	0.5	0.5	0.4	1.2	1.8	4.2	1.0	0.6	2.3	0.8	0.7	1.6	0.4	1.2	1.3	1.0	0.9	2.1	1.3	0.5	0.2	2.2	1.1	0.6	0.2	0.5	0.9	0.5	0.7	2.1	0.6	0.7	0.8	1.6	0.5	12.8	1.0	7.3	0.5	1.1	1.3	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	0.9	0.8	0.7	1.0	0.9	1.1	0.8	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CFAP251	"CaM-IP4, MGC33630, WDR66"	ENSG00000158023	"Cilia and flagella associated protein 251"	Q8TBY9	12	121918592-122003927	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.8	1.6	0.3	2.4	0.1	1.3	1.3	1.7	3.5	13.2	0.2	0.1	1.9	4.7	0.3	22.3	1.2	1.3	2.4	3.9	2.7	1.4	3.0	0.6	5.5	6.6	2.2	1.7	2.9	6.5	0.9	3.6	0.7	0.1	4.6	1.1	1.6	0.3	1.5	0.2	0.6	2.7	1.7	0.4	19.9	4.1	0.5	4.7	0.4	0.9	0.3	1.3	1.6	4.7	0.4	0.4	0.2	0.5	0.5	0.5	0.3	2.5	1.2	3.0	0.3	1.4	0.2	3.7	0.2	0.7	0.9	0.3	31.8	4.4	0.2	0.5	0.2	0.6	0.3	3.7	0.1	8.6	1.8	30.8	2.4	19.9	0.7	1.3	0.5	7.5	0.1	1.9	0.9	0.3	0.6	0.4	0.4	0.2	0.4	0.8	0.0	5.4	0.5	2.5	0.1	0.2	0.1	0.2	0.8	0.9	0.1	1.0	2.5	3.9	0.5	0.5	0.5	0.2	3.8	2.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	1.6	2.4	1.3	1.7	2.4	3.9	5.5	6.6	3.6	2.7	4.1	1.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CFAP43	"bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96"	ENSG00000197748	"Cilia and flagella associated protein 43"	Q8NDM7	10	104129888-104232364	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.7;choroid plexus: 80.2;fallopian tube: 48.9;testis: 57.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.0;Endometrial ciliated cells: 161.0;Late spermatids: 58.4;Respiratory ciliated cells: 231.0;Spermatocytes: 53.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;U-266/70: 3.3;U-266/84: 2.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 5.9"							NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.46e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.11e-4)"	"unprognostic (6.67e-2)"	0.3	1.0	8.4	0.2	8.2	0.2	2.5	4.7	4.3	6.0	80.2	0.3	0.4	2.9	7.8	0.2	48.9	0.9	0.2	8.8	10.5	5.9	0.4	8.2	0.3	33.9	34.7	1.8	2.2	3.8	10.1	0.3	23.5	1.5	0.2	10.7	0.9	1.3	0.1	1.0	0.6	0.2	23.8	0.2	0.6	57.3	9.8	0.4	5.3	0.0	0.2	0.2	0.5	14.6	1.7	0.6	0.6	1.1	0.0	0.3	0.1	0.0	0.5	0.3	0.2	0.0	4.3	0.0	0.0	0.0	1.5	0.6	0.1	0.6	0.7	0.2	0.7	0.0	0.3	0.2	0.1	0.0	0.1	0.4	0.5	0.4	0.3	0.9	0.1	0.3	1.2	0.1	0.0	1.1	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	1.5	0.0	0.9	0.9	0.4	0.0	0.8	0.5	0.5	0.0	0.0	0.1	0.3	0.5	0.2	3.3	2.9	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.4	8.2	4.7	4.3	8.8	10.5	33.9	34.7	23.5	23.8	9.8	14.6	0.3	3.2	8.4	16.6	0.1	0.0	0.6	0.0	0.6	0.8	1.9	1.7	0.8	0.0	38.4	1.8	10.4	0.1	0.0	0.0	0.0	1.2	103.0	161.0	2.1	1.0	3.6	0.8	16.6	0.0	0.2	1.2	1.1	3.6	6.3	0.6	0.4	0.1	0.1	0.0	23.5	0.1	0.0	0.0	0.0	58.4	1.5	0.7	0.0	1.9	0.6	1.3	0.0	1.5	6.1	0.2	0.1	2.2	0.2	0.6	0.1	1.2	231.0	8.8	0.0	0.6	0.1	53.7	4.4	0.3	0.0	0.0	0.7	0.4	0.2	0.3
CFAP44	"FLJ11142, WDR52"	ENSG00000206530	"Cilia and flagella associated protein 44"	Q96MT7	3	113286930-113441610	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.4;Endometrial ciliated cells: 40.0;Late spermatids: 61.2;Respiratory ciliated cells: 104.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.7"	HPA067258	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA067258: AB_2685814"	"unprognostic (2.83e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-6)"	"unprognostic (8.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-2)"	"prognostic favorable (7.09e-6)"	1.6	1.2	1.1	0.9	1.2	0.8	2.5	1.2	1.0	3.7	11.9	2.7	0.7	2.7	2.6	1.6	6.8	1.0	1.7	1.3	1.4	1.9	2.1	2.5	1.3	5.5	4.8	3.3	3.7	1.9	6.3	0.7	2.6	4.2	2.3	8.7	4.9	1.1	1.3	2.3	2.9	0.7	4.4	2.0	3.0	6.1	1.4	1.4	3.2	0.4	1.0	2.4	2.6	2.0	1.1	0.7	1.6	1.4	0.9	1.5	1.5	0.5	0.3	0.3	0.7	0.1	0.6	1.4	0.1	0.2	0.3	1.5	0.9	0.5	0.6	0.3	1.0	0.8	3.4	0.3	0.0	1.5	0.9	0.4	1.4	0.3	0.3	2.0	0.2	1.3	0.2	0.7	0.3	0.7	0.8	1.3	0.5	1.9	1.8	0.8	0.2	0.0	0.8	1.8	1.5	1.4	0.7	0.1	0.8	0.8	1.0	1.1	1.1	0.5	0.8	0.4	0.5	0.9	0.6	0.1	0.7	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.2	1.0	1.3	1.4	5.5	4.8	2.6	4.4	1.4	2.0	3.8	9.6	13.7	27.4	2.9	0.0	2.1	0.0	5.7	7.5	6.7	5.2	5.1	2.8	18.6	3.7	20.9	0.9	1.1	3.2	0.0	2.6	57.4	40.0	6.3	4.2	0.0	1.3	34.8	3.0	1.0	5.2	12.2	9.5	11.4	4.3	1.8	3.7	0.5	8.4	14.0	4.7	0.0	0.6	0.0	61.2	6.2	1.8	0.0	20.6	0.9	4.0	3.1	21.1	21.9	2.1	1.9	6.8	2.5	2.2	2.2	1.1	104.9	19.0	0.0	9.7	2.5	23.6	4.9	1.8	0.0	0.8	2.9	6.2	2.7	2.2
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.1;choroid plexus: 13.5;fallopian tube: 25.7;testis: 9.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 204.5;Late spermatids: 164.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 10.8"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.0	0.1	2.3	0.0	2.1	0.0	0.1	1.0	1.0	1.3	13.5	0.1	0.0	0.5	1.8	0.0	25.7	0.4	0.0	2.6	2.8	0.4	0.0	2.7	0.0	8.4	12.1	0.0	0.3	0.1	3.5	0.0	6.2	0.1	0.2	9.2	0.1	0.1	0.0	0.0	0.4	0.0	6.1	0.0	0.3	9.4	2.4	0.0	0.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.0	1.0	2.6	2.8	8.4	12.1	6.2	6.1	2.4	3.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.8	7.7	8.8	0.0	4.3	6.8	0.0	12.5	0.0	0.1	1.1	0.0	0.6	204.5	45.1	0.5	0.2	29.1	0.0	0.0	1.5	0.0	0.2	2.0	1.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	25.2	0.0	0.0	0.0	164.3	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.8	0.7	0.0	1.1	1.9	1.1	29.2	19.5	0.0	0.1	0.0	14.4	5.7	0.0	0.0	0.0	0.2	0.1	5.1	0.1
CFAP69	"C7orf63, FAP69, FLJ21062"	ENSG00000105792	"Cilia and flagella associated protein 69"	A5D8W1	7	90245174-90311063	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Olfaction, Sensory transduction, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.4;Endometrial ciliated cells: 55.3;Excitatory neurons: 57.6;Inhibitory neurons: 46.4;Respiratory ciliated cells: 51.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062883	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA062883: AB_2684893"	"unprognostic (7.69e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.44e-3)"	8.0	3.0	3.5	1.7	3.9	0.0	8.0	3.0	5.1	6.9	20.4	6.0	1.9	4.6	12.5	3.0	14.3	3.1	5.0	3.6	3.8	8.1	6.6	7.4	0.4	7.0	6.7	6.9	4.8	5.1	11.8	0.7	4.8	24.8	2.1	11.9	5.8	3.0	1.9	4.4	3.4	3.4	5.4	3.6	4.5	7.7	4.4	0.1	10.2	0.6	0.7	4.6	3.8	4.5	2.8	1.7	0.2	3.2	3.5	3.6	0.6	0.1	2.5	1.0	1.5	6.0	2.4	0.3	0.1	2.9	3.9	1.0	1.1	1.4	1.7	0.0	1.1	0.0	0.8	1.7	2.0	0.3	0.0	4.1	1.6	4.2	1.5	5.6	1.1	0.3	1.4	0.0	1.8	1.6	0.0	2.6	1.6	0.1	0.8	0.0	0.4	0.0	5.6	0.7	0.6	1.4	2.6	0.3	0.7	0.6	1.0	0.1	0.2	3.2	0.7	3.2	1.1	0.6	0.2	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.9	3.0	5.1	3.6	3.8	7.0	6.7	4.8	5.4	4.4	4.5	1.5	3.2	6.3	28.4	0.2	0.0	1.5	0.0	3.4	4.8	5.5	4.3	3.0	8.6	6.8	5.5	18.8	0.2	0.0	0.9	1.9	1.9	24.1	55.3	5.6	1.0	0.0	0.8	57.6	1.6	0.1	9.1	2.6	3.4	0.0	4.2	1.1	1.6	0.1	8.4	46.4	0.8	0.0	0.3	0.0	6.2	1.2	0.4	0.0	12.2	0.0	4.2	0.0	13.0	8.2	0.6	1.0	2.2	0.0	7.0	1.9	3.7	51.7	18.2	0.0	9.5	3.8	22.7	1.8	1.5	0.0	0.1	0.1	4.9	1.1	1.4
CFAP70	"FLJ25765, TTC18"	ENSG00000156042	"Cilia and flagella associated protein 70"	Q5T0N1	10	73253759-73358859	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.4;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Early spermatids: 61.9;Endometrial ciliated cells: 153.6;Respiratory ciliated cells: 179.3;Spermatocytes: 60.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037582, HPA070304"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037582: AB_2675560, HPA070304: AB_2732153"	"unprognostic (2.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	1.3	4.5	4.3	0.5	4.4	0.3	3.1	3.9	4.9	2.8	24.4	0.7	1.2	1.6	11.3	0.6	14.7	1.4	1.3	4.9	5.5	7.8	2.3	3.1	0.7	10.0	12.5	3.2	2.9	4.7	13.5	0.5	8.4	4.3	0.6	10.5	2.3	1.9	0.9	2.9	0.7	0.5	8.4	1.4	1.3	20.9	5.0	0.6	6.3	0.6	0.8	0.9	1.1	6.2	1.1	1.3	1.4	1.2	2.4	2.1	0.4	0.5	0.1	0.3	0.4	1.0	4.6	0.5	0.7	0.2	0.9	0.7	0.8	1.0	0.5	1.0	2.3	1.0	1.0	1.1	0.2	0.5	0.6	1.3	2.3	0.7	0.6	1.7	0.0	3.1	0.4	2.9	0.4	1.8	1.3	1.0	0.5	1.1	5.4	0.8	1.2	2.4	2.3	0.3	1.9	0.2	0.4	0.9	0.9	0.8	1.8	0.8	0.8	0.3	1.2	0.5	1.3	3.0	1.8	1.5	1.7	1.0	0.4	0.0	0.0	0.4	0.3	0.1	0.7	0.5	0.6	0.5	0.2	0.8	1.3	1.1	0.1	0.5	0.1	0.4	0.6	0.2	4.3	4.4	3.9	4.9	4.9	5.5	10.0	12.5	8.4	8.4	5.0	6.2	2.0	9.6	8.4	68.6	2.2	0.0	3.6	0.0	2.8	15.3	6.7	3.9	2.1	1.5	36.5	5.5	29.2	1.4	0.3	0.3	3.9	1.9	61.9	153.6	3.3	1.8	4.9	0.4	29.5	0.6	0.2	3.2	3.1	7.4	2.5	3.2	4.6	2.6	0.5	6.7	37.6	0.5	0.0	0.3	0.0	39.0	4.7	1.1	0.0	5.6	0.1	16.0	0.0	12.1	22.4	0.2	0.1	3.0	1.3	5.5	0.5	2.8	179.3	28.0	6.6	5.3	1.1	60.4	14.8	2.0	0.0	0.3	1.3	8.1	0.8	2.5
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439838-108697545	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.9"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 713.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 87.7;HHSteC: 95.0;HUVEC TERT2: 92.8;TIME: 88.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077177			Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Vesicles	"HPA077177: "	"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	7.4	5.6	25.2	2.3	57.4	0.0	8.1	38.2	40.8	38.1	20.0	5.8	3.8	59.2	25.4	9.6	37.5	18.2	10.9	27.0	33.7	16.9	2.4	8.5	1.2	47.7	43.1	23.0	3.8	16.8	19.7	14.5	47.4	37.0	5.6	6.1	7.4	32.9	7.6	26.4	6.3	47.2	36.4	5.5	34.5	6.0	45.3	2.7	10.5	4.4	1.0	47.6	22.7	102.9	4.5	26.7	47.2	14.9	18.0	10.6	0.3	2.8	11.7	14.2	23.2	24.0	1.9	4.2	0.0	2.0	8.6	21.7	13.2	45.2	17.8	6.7	11.7	3.4	87.7	2.9	95.0	0.0	13.5	49.2	53.6	17.4	37.2	45.2	92.8	0.0	0.2	0.1	13.9	2.0	0.1	0.5	14.0	0.0	16.0	0.1	0.0	0.2	35.9	26.7	0.0	0.0	70.2	2.2	6.0	65.6	12.9	0.0	88.8	9.5	2.8	6.4	4.0	1.9	0.0	0.0	8.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	57.4	38.2	40.8	27.0	33.7	47.7	43.1	47.4	36.4	45.3	102.9	1.0	6.4	7.3	72.5	0.0	26.9	29.7	29.4	17.1	0.5	14.8	14.7	10.0	2.8	14.2	20.2	0.0	0.7	0.0	0.0	0.0	0.4	0.1	7.4	45.4	4.6	0.0	0.0	1.1	0.9	0.4	12.3	3.1	5.7	1.3	2.0	4.2	0.5	0.4	0.0	1.5	0.2	6.1	0.3	2.1	1.7	20.2	0.6	1.8	20.6	0.0	11.1	0.0	3.5	713.9	0.4	0.0	36.9	0.0	18.1	0.0	0.1	8.2	0.6	6.6	2.4	18.3	0.4	0.9	4.2	15.9	0.7	1.1	21.5	0.1	24.7
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 32.6;urinary bladder: 40.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 24.5;Basal respiratory cells: 16.0;Cardiomyocytes: 13.1;Prostatic glandular cells: 12.1;Urothelial cells: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.0;HeLa: 40.1;HHSteC: 59.2;hTERT-HME1: 44.1;HUVEC TERT2: 41.7;TIME: 94.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	3.0	0.5	0.3	0.4	0.3	0.0	2.0	0.2	0.2	12.6	1.3	1.9	1.4	32.6	17.0	5.5	14.9	13.3	5.4	0.3	0.7	4.2	0.1	1.0	0.1	0.9	1.7	9.3	0.1	5.5	7.2	3.2	1.0	12.5	2.1	1.2	1.4	21.5	1.4	6.5	1.5	24.5	0.4	1.4	13.3	1.2	0.3	0.9	0.7	1.2	0.1	40.7	9.2	0.6	0.1	31.1	9.9	0.0	24.2	1.7	0.0	0.0	1.8	0.3	0.2	17.9	0.0	0.0	0.0	0.0	3.9	5.8	10.3	46.0	0.8	0.4	8.8	0.8	40.1	0.3	59.2	0.0	0.0	2.6	27.8	6.5	44.1	0.1	41.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.0	0.0	3.8	0.0	0.0	0.0	1.9	3.4	0.0	0.0	2.4	0.0	0.0	18.2	0.9	0.0	94.2	0.0	0.1	5.5	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.7	0.9	1.7	1.0	0.4	0.3	0.6	0.1	0.0	0.0	6.2	0.0	6.4	24.5	16.0	3.4	0.2	2.3	6.1	13.1	0.0	2.6	1.8	0.0	0.1	0.0	0.0	1.9	0.0	2.1	0.7	6.0	0.4	0.0	0.0	0.4	0.0	0.0	6.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	2.0	0.0	0.3	0.3	4.1	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.6	0.1	0.0	9.1	0.0	12.1	0.0	0.0	2.2	0.4	0.0	0.4	7.2	0.2	0.2	0.1	3.7	0.0	0.1	0.8	0.0	15.2
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog signaling molecule"	O43323	12	49086656-49094801	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 16.7"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 17.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"spinal cord: 8.2"						"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.8	0.2	0.2	0.5	0.3	0.0	0.7	0.7	0.5	0.5	0.1	0.4	0.0	0.6	0.2	0.3	0.4	0.3	0.6	0.2	0.1	0.7	0.1	0.5	0.1	0.5	0.4	0.3	0.1	0.0	0.6	0.6	0.4	0.4	0.1	0.0	0.3	0.3	0.1	0.3	0.4	0.4	0.6	0.2	0.3	16.7	0.4	0.0	0.3	0.4	0.0	0.7	0.5	0.8	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.5	0.2	0.1	0.5	0.4	0.4	0.6	0.4	0.8	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	10.7	3.3	3.7	6.4	6.4	17.7	7.0	0.0	4.3	10.6	17.3	8.6	4.3	5.5	3.5	7.7	6.7	5.7	5.4	6.4	3.1	3.1	12.3	8.2	3.8	0.6	0.9	7.7	4.9	7.0	2.0	12.5	1.0	6.1	8.7	3.0	6.6	7.6	12.0	5.3	5.3	7.4	0.2	3.8	7.4	9.4	1.5	6.0	3.9	9.1	3.9	7.4	9.8	1.8	0.0	6.5	3.1	6.3	17.1	28.3	0.0	11.2	11.8	5.9	12.4	5.5	12.3	18.5	8.7	9.7	11.3	0.0	16.6	1.7	7.6	0.5	9.5	0.0	7.4	5.9	14.2	24.3	8.2	14.3	6.0	8.0	24.6	8.0	11.6	13.6	0.0	14.9	11.2	5.3	9.2	10.0	24.4	0.1	9.4	0.0	16.5	0.0	3.4	9.8	0.0	6.3	0.0	3.2	9.0	18.8	2.7	13.2	14.8	12.6	5.8	10.6	7.3	0.2	0.0	15.3	10.7	24.1	7.6	0.0	3.1	3.3	1.1	2.8	0.9	1.7	1.2	1.4	2.3	1.3	0.8	0.7	0.3	0.7	2.5	2.2	0.7	0.6	3.7	6.4	0.0	4.3	6.4	3.1	0.6	0.9	1.0	0.2	1.5	1.8	61.7	32.1	51.1	21.2	18.8	10.8	6.8	11.9	11.4	5.5	9.9	8.1	20.2	15.7	15.0	20.2	0.0	65.2	21.5	36.6	7.9	18.6	80.5	51.2	46.2	31.2	24.6	6.1	171.0	23.4	16.8	35.2	41.8	41.7	7.6	36.1	8.2	26.1	21.0	0.0	90.0	32.3	4.1	29.6	19.3	177.8	45.1	34.7	8.8	301.7	32.7	13.0	10.3	281.0	41.2	38.4	39.3	20.3	11.6	8.0	11.9	9.4	57.1	13.7	26.3	46.7	32.7	7.5	12.9	17.6	18.3	118.3	19.0	19.0	32.5	6.0
DNAH1	"DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1"	ENSG00000114841	"Dynein axonemal heavy chain 1"	Q9P2D7	3	52316319-52400491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 21.5;Respiratory ciliated cells: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"HPA036805, HPA036806"	Uncertain					NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036805: AB_10670924, HPA036806: AB_10670849"	"unprognostic (8.34e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.60e-4)"	"unprognostic (1.54e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.59e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.84e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.80e-5)"	2.1	1.4	0.2	2.1	0.7	6.2	1.7	0.0	1.1	1.4	2.1	1.4	1.3	1.5	1.3	1.3	4.0	1.6	1.0	0.3	0.5	1.5	2.4	2.4	3.1	1.3	1.7	1.9	1.5	1.4	1.8	1.0	0.8	1.6	1.3	2.5	1.5	0.7	1.1	1.7	2.9	1.7	0.3	2.9	1.6	4.1	0.6	1.9	1.5	0.5	2.4	1.1	1.1	1.8	0.1	0.7	1.0	1.0	1.2	4.6	0.5	0.6	1.0	0.2	0.2	0.0	0.6	0.3	0.6	0.8	0.1	0.1	0.0	0.2	0.4	0.8	1.4	2.0	0.1	0.2	0.6	1.5	1.3	2.0	0.3	0.8	1.0	2.1	0.8	0.8	0.2	1.7	0.8	0.2	0.4	1.4	0.5	0.1	0.9	0.7	0.0	0.6	0.3	0.8	0.1	0.5	1.0	0.1	0.7	0.3	0.2	2.4	1.0	0.3	0.2	0.9	0.2	1.8	1.8	0.5	0.3	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.1	0.3	0.5	1.3	1.7	0.8	0.3	0.6	1.8	2.2	6.4	3.7	9.1	3.2	0.5	0.4	2.0	0.6	1.8	1.7	1.8	4.4	0.0	2.7	0.0	4.2	0.6	3.1	2.3	0.0	0.3	9.7	6.9	1.6	2.1	5.4	2.7	13.8	0.6	0.2	1.2	8.2	3.8	3.8	3.2	2.2	3.9	1.2	5.0	10.0	2.6	8.2	3.5	1.6	21.5	1.2	3.2	1.8	3.7	3.4	0.9	4.1	2.5	10.7	0.3	2.1	0.4	2.4	0.9	4.8	0.9	35.5	5.2	0.0	1.4	1.9	6.9	1.5	1.1	0.3	0.8	3.3	1.7	2.2	0.6
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 9.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	6.7	5.3	4.0	0.5	3.9	3.0	4.7	7.0	6.9	11.4	6.6	5.2	0.6	7.8	4.1	1.4	6.4	2.8	19.2	3.0	4.3	12.7	0.2	1.3	0.9	2.4	3.0	11.0	2.7	9.0	10.5	1.2	1.5	9.3	1.3	14.4	1.6	4.7	0.5	1.6	1.7	3.5	0.8	1.7	2.9	65.6	3.3	0.7	13.1	0.6	0.6	6.3	5.1	4.2	1.0	2.6	2.2	5.4	0.6	0.0	0.2	1.8	1.8	2.4	3.1	0.4	0.8	2.8	1.8	0.7	2.9	0.4	2.7	0.3	3.6	1.5	1.7	4.6	1.4	1.7	0.5	3.4	1.4	1.5	0.1	1.1	0.0	6.1	0.8	2.2	1.9	2.9	3.9	1.7	0.2	1.4	2.1	0.4	2.4	0.0	1.8	0.0	4.6	0.5	7.0	0.7	0.6	0.2	1.0	0.9	1.9	0.9	0.5	3.2	4.2	0.5	4.6	7.5	9.3	0.0	3.4	1.6	3.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	4.0	3.9	7.0	6.9	3.0	4.3	2.4	3.0	1.5	0.8	3.3	4.2	6.7	3.2	0.0	23.2	0.2	0.5	2.9	0.1	2.2	49.6	1.9	1.8	32.3	1.5	3.8	12.9	14.6	2.0	0.3	0.1	5.9	0.4	329.9	5.6	7.1	1.7	0.0	7.2	124.1	0.0	1.3	2.2	0.5	2.1	2.5	1.2	1.4	0.1	0.3	3.3	137.2	0.1	6.1	0.0	0.4	363.0	7.2	0.4	7.2	11.2	0.1	9.2	0.0	124.1	5.0	0.2	0.0	8.6	0.5	2.9	0.0	6.4	11.6	6.7	26.3	3.8	19.9	143.3	4.9	0.2	0.4	1.4	0.8	3.6	0.1	1.1
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 6.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.1"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	1.5	6.1	1.2	1.2	0.6	1.0	0.9	3.0	0.8	1.4	3.5	0.9	1.0	1.2	0.4	0.7	1.0	0.5	0.6	0.5	0.9	1.5	0.7	0.6	2.1	0.7	0.6	5.4	2.1	0.1	0.8	0.2	1.0	1.5	1.0	2.0	0.8	0.2	1.4	1.0	1.3	0.3	0.3	1.8	1.0	5.7	1.7	2.5	0.6	0.2	1.6	1.1	0.6	0.9	0.8	0.4	0.7	0.6	0.0	0.1	1.5	0.2	0.0	0.1	0.1	0.3	0.9	3.1	0.1	0.1	0.4	1.0	0.8	0.0	0.1	0.7	0.4	0.3	1.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	1.1	0.5	4.2	0.2	0.8	0.5	0.2	0.7	0.6	0.4	0.5	0.4	0.3	0.1	1.3	2.2	0.6	0.4	0.2	1.1	0.4	0.7	0.1	0.5	0.4	1.0	0.2	0.1	9.8	3.1	16.4	0.2	0.1	0.8	0.3	0.1	0.5	0.3	0.2	0.2	0.5	0.2	0.4	0.0	0.7	0.4	0.3	0.6	0.2	0.3	1.1	0.2	0.1	1.2	0.6	3.0	0.8	0.5	0.9	0.7	0.6	1.0	0.3	1.7	0.9	0.9	6.4	0.0	6.8	5.5	0.3	2.2	0.4	2.8	1.6	0.3	0.1	0.9	4.3	0.9	0.0	6.2	0.7	5.2	0.1	0.0	0.3	61.4	3.5	0.9	3.0	0.0	0.4	12.4	0.7	0.5	2.2	0.0	4.9	1.3	26.6	1.1	0.1	0.1	0.0	17.9	0.8	0.0	0.0	0.3	93.7	0.9	0.2	1.8	7.5	0.1	0.9	6.2	10.6	7.6	0.5	0.1	1.2	16.6	3.8	0.4	0.1	1.7	35.6	0.0	1.5	1.4	28.0	1.4	0.5	0.1	1.1	3.0	16.4	0.8	1.8
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
FIGLA	bHLHc8	ENSG00000183733	"Folliculogenesis specific bHLH transcription factor"	Q6QHK4	2	70777310-70790643	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"retina: 1.1"	"Group enriched"	"Detected in some"	17	"Early spermatids: 1.9;Late spermatids: 6.4;Spermatogonia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071241	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA071241: "				"unprognostic (1.82e-1)"						"unprognostic (4.04e-1)"					"unprognostic (1.73e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"FMRP translational regulator 1"	Q06787	X	147911919-147951125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	18.1	16.5	22.3	20.6	24.1	43.5	18.3	29.6	29.2	18.8	16.1	19.1	17.5	27.3	41.0	17.0	22.8	15.9	20.1	21.7	21.0	34.0	39.6	20.1	22.7	21.9	21.1	27.7	13.3	29.6	13.5	31.2	21.3	16.5	18.9	27.6	14.1	21.4	9.5	23.2	19.7	21.1	22.7	27.7	17.8	19.6	22.9	24.6	30.6	11.6	21.7	16.7	14.7	23.4	44.9	39.6	41.2	27.2	24.4	19.4	31.9	23.8	24.9	37.6	66.4	43.5	42.1	89.5	93.5	29.8	43.3	74.4	65.8	30.2	42.0	34.9	45.2	25.3	71.3	41.4	24.0	28.3	15.1	21.2	16.2	31.6	28.8	22.6	31.8	24.4	15.9	57.7	32.7	59.0	32.0	20.3	18.2	30.9	21.8	34.7	116.8	37.6	43.2	119.3	35.1	23.3	26.8	24.4	35.7	55.4	21.8	24.9	30.4	30.5	25.5	37.7	60.0	61.1	65.5	94.5	27.4	46.9	16.3	2.0	1.3	3.4	2.7	1.6	3.5	2.6	1.8	3.1	1.7	2.4	2.3	2.7	3.5	2.5	1.6	1.3	2.4	1.3	22.3	24.1	29.6	29.2	21.7	21.0	21.9	21.1	21.3	22.7	22.9	23.4	35.3	57.7	26.6	26.8	22.1	31.4	16.0	12.6	21.1	37.5	20.7	17.4	43.2	14.3	23.9	22.0	12.5	37.2	37.1	27.2	19.6	14.7	1.0	36.4	42.5	27.2	14.9	10.7	33.3	9.8	43.5	27.2	17.9	49.3	19.7	36.8	17.5	37.5	15.4	70.7	32.2	13.8	18.3	25.4	15.7	3.0	30.1	23.7	35.6	29.0	16.8	40.0	11.3	28.6	33.9	13.5	18.1	29.7	20.3	22.7	20.7	42.6	23.4	30.0	6.6	37.2	33.3	14.9	20.9	28.1	32.4	40.8	24.1	39.4	16.9	34.7
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947137	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 208.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069613	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	2.6	1.0	0.0	0.8	0.0	0.0	0.6	0.8	12.8	0.3	0.0	0.0	7.3	0.4	0.0	11.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.8	0.8	44.8	0.1	12.5	10.0	0.1	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.8	0.0	0.0	0.7	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.7	4.9	1.8	0.2	3.4	0.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.3	0.0	2.2	5.6	0.2	1.1	0.0	0.0	0.1	0.0	0.0	8.1	0.9	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.0	1.1	0.0	0.0	8.4	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.6	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.6	0.8	0.6	0.6	0.8	0.8	0.8	0.8	1.2	0.7	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	41.8	1.6	0.0	0.0	0.0	0.2	0.3	20.9	0.0	1.0	0.0	208.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.2	1.8	1.4	0.0	1.0	0.0	0.3	48.4	0.0	0.0
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154527	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 1.0;ovary: 2.0;testis: 2.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 10.1;Granulosa cells: 33.8;Late spermatids: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 40: Granulosa cells - Unknown function"													"unprognostic (5.94e-2)"			"unprognostic (4.06e-3)"		"unprognostic (5.78e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.8	2.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.0	0.6	0.8	0.4	0.3	0.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
FSIP2	FLJ34780	ENSG00000188738	"Fibrous sheath interacting protein 2"	Q5CZC0	2	185738804-185833290	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 18.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 137.8;Alveolar cells type 2: 93.8;Early spermatids: 289.6;Gastric mucus-secreting cells: 68.3;Spermatocytes: 124.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036139			Approved	Microtubules,Mitochondria		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Microtubules	Mitochondria	"HPA036139: AB_10602134"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.64e-5)"	0.1	0.2	0.3	0.2	0.5	0.0	0.2	0.3	0.3	0.2	0.0	1.5	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.2	0.4	0.1	0.6	0.2	0.9	0.6	0.2	0.0	0.0	0.2	0.2	0.0	0.6	0.0	2.6	18.3	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.2	0.3	0.5	0.4	0.6	0.6	0.3	0.9	1.7	137.8	93.8	5.2	2.6	0.5	0.1	1.4	1.8	16.3	3.0	1.7	3.9	0.0	31.5	0.0	10.4	0.3	1.0	26.0	0.0	0.7	289.6	3.3	3.3	5.6	7.7	0.0	4.5	0.2	0.1	7.3	68.3	2.1	40.4	2.7	1.8	0.1	0.4	18.5	5.4	19.7	0.0	0.8	1.0	50.8	2.1	5.9	1.8	3.7	0.7	3.9	2.1	23.6	14.0	5.4	5.5	3.8	1.3	0.2	0.5	0.2	46.0	7.2	0.0	4.0	0.8	124.4	5.4	0.2	0.3	0.3	6.0	2.6	5.2	0.2
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.3	0.2	1.5	0.3	0.8	1.3	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.3	1.4	1.4	0.6	0.3	0.5	1.2	1.4	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.0	0.4	0.2	1.4	0.4	1.0	8.9	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.4	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.3	2.0	1.3	1.4	1.2	1.4	1.4	1.4	1.3	1.4	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.1;testis: 36.7"	"Group enriched"	"Detected in some"	6	"Leydig cells: 108.1;Oligodendrocytes: 93.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;HEL: 1.0;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	1.6	0.8	3.1	0.2	4.3	0.0	1.7	3.4	5.9	3.1	2.4	2.7	0.5	1.5	0.9	0.7	3.5	0.2	2.1	3.1	3.6	4.7	15.1	1.8	0.0	4.3	3.9	1.4	4.2	0.0	1.7	0.1	4.2	3.2	0.1	0.7	1.0	0.1	0.5	0.9	3.7	0.0	3.3	0.9	1.4	36.7	4.2	0.1	10.0	0.1	0.0	1.6	1.8	5.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	4.3	3.4	5.9	3.1	3.6	4.3	3.9	4.2	3.3	4.2	5.4	0.0	0.0	0.0	15.3	0.2	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	4.0	0.2	0.0	0.4	1.8	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.5	0.0	0.0	0.4	14.4	108.1	1.1	0.0	4.7	0.1	0.6	0.0	1.0	93.2	0.2	0.1	12.8	0.0	0.1	0.6	0.0	0.5	0.2	0.0	0.1	0.5	1.9	1.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362658-73364171	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	3156	"testis cancer: 254.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA043699	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 33: Fibroblasts - ECM organization"			"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL10	FLJ32662	ENSG00000161594	"Kelch like family member 10"	Q6JEL2	17	41835685-41848384	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 57.3"	"Group enriched"	"Detected in some"	21	"Early spermatids: 363.3;Late spermatids: 532.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067538	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA067538: AB_2685859"	"unprognostic (3.46e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.17e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.5	0.3	0.0	0.9	0.1	0.4	1.5	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.9	0.2	0.1	0.3	0.7	0.0	0.1	0.4	57.3	0.2	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	363.3	0.1	0.4	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	532.8	3.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	6.0	0.1	0.1	0.0	0.1	0.0	2.6	0.0	0.2	0.2	21.1	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1
LHCGR	"HHG, LCGR, LGR2, LHR, ULG5"	ENSG00000138039	"Luteinizing hormone/choriogonadotropin receptor"	P22888	2	48686774-48755730	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;ovary: 2.1;testis: 2.2"	"Cell type enriched"	"Detected in some"	22	"Theca cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009814	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 52: Non-specific - Transcription"			"CAB009814: AB_2135467"	"unprognostic (8.57e-2)"				"unprognostic (1.08e-1)"			"unprognostic (1.54e-1)"		"unprognostic (1.41e-1)"			"unprognostic (3.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.22e-2)"		1.3	0.8	0.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.1	0.0	3.2	0.7	2.1	0.0	0.0	0.5	0.0	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	2.2	0.8	0.2	0.6	0.1	0.0	0.3	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.9	0.5	0.2	0.6	3.2	0.7	2.0	1.6	0.8	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	1.0	1.2	0.1	0.0	6.5	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	143.2	0.0	0.0
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815549-56896152	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.5;THP-1: 51.0"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 18.2"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	5.5	3.8	3.0	13.3	2.6	24.0	20.1	4.0	2.1	7.0	6.2	5.4	6.3	7.5	6.6	10.0	9.7	5.7	3.7	2.1	2.7	9.9	6.0	7.5	18.1	3.9	3.2	7.2	9.8	7.1	1.3	11.4	3.7	5.4	6.3	26.9	18.5	8.3	1.7	19.7	6.5	5.7	3.8	20.5	8.1	8.3	3.5	9.9	16.2	4.4	24.0	6.7	6.4	3.9	13.3	7.9	12.1	8.1	1.9	1.5	20.3	2.5	3.3	7.6	10.6	37.1	9.7	11.9	0.9	3.0	6.5	6.7	10.1	4.6	10.5	4.0	4.4	6.6	3.4	17.5	4.7	10.6	17.6	1.9	4.8	2.4	3.8	2.1	3.3	4.0	5.8	20.7	2.0	5.8	7.4	14.2	5.6	6.8	1.0	11.5	8.6	41.1	13.2	13.6	5.1	52.5	7.6	9.5	21.5	10.7	26.0	51.0	9.8	0.7	6.4	2.9	4.7	15.0	8.2	22.1	1.2	6.1	13.2	6.3	3.1	0.7	0.8	4.5	0.7	4.0	2.4	1.1	1.8	3.3	1.5	0.5	1.7	1.7	4.9	1.0	3.8	1.7	3.0	2.6	4.0	2.1	2.1	2.7	3.9	3.2	3.7	3.8	3.5	3.9	20.8	6.4	9.8	17.9	102.5	52.4	15.1	17.1	43.9	14.9	73.2	30.6	3.5	48.6	15.9	36.8	47.9	15.1	31.9	7.3	7.9	18.9	2.0	25.0	20.6	24.0	10.2	14.5	11.7	14.8	8.6	10.7	14.3	43.7	7.6	20.0	21.8	15.0	32.3	28.6	31.8	11.4	6.1	76.0	48.4	3.6	5.3	66.5	37.4	69.3	99.1	11.6	9.2	210.1	12.5	12.9	7.7	1.9	41.5	14.8	10.6	20.7	11.0	38.5	6.6	9.3	11.9	8.6	17.9	69.1	54.7	6.7	31.6	15.4	9.7	12.0
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MED12	"ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230"	ENSG00000184634	"Mediator complex subunit 12"	Q93074	X	71118556-71142454	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003184, HPA003185"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA003184: AB_1079349, HPA003185: AB_1079350"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.89e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.16e-2)"	18.9	32.3	10.1	13.4	11.6	15.1	19.3	10.8	12.2	20.3	9.3	15.2	8.1	18.1	10.7	13.4	17.8	8.5	13.4	9.7	10.5	13.1	10.3	15.2	13.6	12.3	10.9	28.9	14.9	14.1	16.3	16.8	11.3	17.4	9.2	8.2	14.3	12.6	15.4	14.7	15.9	12.6	10.2	28.4	15.5	13.4	11.2	19.1	18.1	10.6	12.2	15.2	17.1	12.0	14.2	16.4	25.5	15.3	18.3	16.1	37.1	9.9	14.0	15.2	10.8	19.8	13.1	18.5	12.7	17.2	10.5	13.8	29.7	12.3	12.1	19.6	23.0	30.7	37.9	27.5	14.3	28.8	26.2	18.9	13.2	20.0	23.3	19.6	23.8	23.1	29.0	31.6	15.2	24.3	30.5	16.3	14.7	18.2	21.3	28.0	28.5	14.0	11.8	27.5	14.0	16.9	22.7	11.8	12.2	26.2	13.9	14.2	21.1	16.5	19.7	15.4	7.0	15.4	9.5	13.7	9.8	15.8	11.2	6.9	2.1	4.3	3.0	1.9	2.5	2.0	2.1	2.8	2.1	1.9	2.3	2.0	4.1	2.7	1.3	2.8	4.4	2.4	10.1	11.6	10.8	12.2	9.7	10.5	12.3	10.9	11.3	10.2	11.2	12.0	15.4	9.6	4.2	7.2	8.4	6.0	6.3	6.5	4.6	7.2	8.6	11.0	9.3	11.5	7.6	9.2	6.2	20.7	10.9	10.8	1.9	6.9	0.4	7.9	8.9	12.8	7.8	13.7	3.8	6.3	8.0	8.2	8.6	7.1	9.5	21.1	14.6	4.4	9.1	13.5	4.2	5.8	2.0	6.5	9.8	2.3	14.0	8.9	5.4	6.5	7.4	6.3	13.4	4.0	4.2	9.4	10.0	13.5	7.3	7.5	7.5	2.7	7.5	4.9	0.0	10.0	7.6	6.6	7.3	6.1	5.7	27.2	8.8	27.9	6.8	8.6
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699503-41799456	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.4"	HPA049240	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favorable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	1.3	1.0	2.3	6.7	4.0	12.1	3.0	2.1	2.9	1.5	1.7	6.4	2.6	0.7	0.3	1.6	1.8	1.3	1.0	2.1	2.2	2.8	1.4	4.5	6.6	2.5	3.5	0.8	0.6	0.1	0.9	0.8	2.3	1.5	3.0	1.3	7.0	0.5	0.5	1.2	8.5	0.8	2.1	22.4	4.4	39.5	4.9	2.5	2.3	0.1	8.1	2.7	1.3	2.6	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.3	0.6	0.2	0.5	0.5	0.2	0.2	0.2	0.0	0.0	0.0	6.7	0.0	2.0	11.6	1.3	1.8	1.4	8.5	0.1	0.1	0.0	0.0	0.3	0.5	0.8	0.4	26.8	0.1	0.0	0.0	6.5	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	3.7	1.0	0.5	0.0	0.0	0.1	29.9	5.1	1.2	0.4	2.8	0.1	18.5	7.2	15.7	29.9	5.6	29.1	21.7	30.1	25.8	6.5	15.4	21.7	24.0	1.3	16.9	2.3	2.3	57.2	18.1	2.3	4.0	2.1	2.9	2.1	2.2	2.5	3.5	2.3	2.1	4.9	2.6	0.7	0.0	3.2	0.0	32.8	0.9	0.3	0.3	0.0	0.6	0.3	0.3	0.9	0.0	0.1	0.0	0.0	0.1	19.9	0.0	0.0	0.1	61.3	0.3	1.0	1.4	0.0	0.4	2.1	0.0	0.2	2.0	2.0	0.1	14.0	0.5	3.3	0.5	7.0	0.0	1.1	2.9	0.0	1.2	3.5	50.8	0.6	11.1	17.8	3.7	15.5	0.1	29.9	1.0	1.1	5.3	0.0	1.2	94.7	0.3	0.1	0.4	0.1	1.1	0.0	0.7	1.7	38.1	26.1	0.0	1.0	0.0	28.4	0.1	0.4	0.3
MEIOB	"C16orf73, MGC35212"	ENSG00000162039	"Meiosis specific with OB-fold"	Q8N635	16	1833986-1884294	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	34	"testis: 37.0"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 499.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 27.6;K-562: 92.7;THP-1: 76.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (7.18e-2)"	"unprognostic (1.91e-1)"			"unprognostic (3.04e-2)"		"unprognostic (9.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.00e-2)"		"unprognostic (2.68e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.80e-1)"		"unprognostic (2.18e-3)"	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	1.0	0.3	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.8	0.0	0.0	0.1	0.7	0.2	0.0	0.1	0.0	0.1	37.0	0.2	0.9	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.7	0.1	0.0	1.5	0.0	0.0	4.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	9.4	0.8	0.0	0.4	1.1	76.2	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.5	58.0	0.1	0.3	0.2	0.0	0.0	2.6	0.0	0.2	0.2	0.0	0.2	4.5	2.3	0.0	0.0	0.1	3.3	4.1	0.0	0.0	0.0	0.0	15.9	1.8	0.2	0.0	0.0	0.0	0.1	0.0	1.0	2.1	0.1	0.0	1.5	0.0	0.3	0.0	3.4	0.0	0.3	6.6	0.0	0.3	499.7	75.2	0.6	0.4	0.0	0.0	0.8	0.0	0.4
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	25.5	55.6	23.1	20.7	24.2	37.9	25.2	27.2	31.5	21.9	22.2	35.0	37.0	20.2	19.3	37.4	20.5	17.3	61.3	23.4	27.3	38.0	57.4	17.0	22.8	24.9	23.4	22.6	32.0	31.7	13.7	25.6	26.0	17.1	31.9	17.9	22.0	20.2	83.0	21.8	33.1	23.9	25.8	17.0	25.0	35.4	24.4	23.5	22.8	77.3	24.4	27.3	21.6	27.4	101.2	40.4	40.0	44.5	49.1	41.7	79.1	58.9	72.3	97.1	80.7	130.0	68.3	66.5	106.9	67.1	98.9	109.9	64.6	76.5	96.4	39.0	64.1	105.2	35.8	97.2	56.2	99.3	58.1	45.2	59.6	58.3	61.8	49.2	61.0	76.2	149.2	41.7	61.2	72.4	51.9	85.9	64.4	102.3	73.3	65.0	61.3	98.9	75.0	61.4	43.4	40.4	94.2	141.4	154.6	37.0	97.1	93.7	47.5	42.4	42.3	82.4	55.9	66.3	38.5	119.5	56.9	70.6	42.3	42.8	38.4	36.1	34.9	53.4	43.0	40.3	37.5	39.4	45.8	36.1	41.0	38.9	9.2	38.1	53.6	29.7	47.6	36.3	23.1	24.2	27.2	31.5	23.4	27.3	24.9	23.4	26.0	25.8	24.4	27.4	30.7	19.2	13.4	8.8	21.8	22.8	29.7	63.3	19.4	19.9	15.3	18.0	50.3	25.8	33.3	18.4	14.6	62.9	24.9	26.5	68.4	47.5	84.3	19.9	30.5	26.6	15.6	31.2	8.7	60.3	48.0	27.7	16.3	22.0	27.3	24.9	18.2	38.9	48.6	20.2	13.8	26.5	32.6	21.9	16.1	14.3	23.3	22.5	16.0	4.7	38.0	21.8	24.7	10.1	10.1	42.0	27.1	23.7	38.4	16.6	45.4	59.4	35.5	26.2	39.5	32.2	39.1	102.2	51.4	34.8	20.5	75.4	24.7	74.1	46.5	31.2
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739677-31762676	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 5.2"									HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	1.3	1.2	0.1	0.5	0.1	0.7	1.5	0.1	0.4	1.7	0.2	1.6	0.0	1.4	0.0	2.2	1.9	0.0	1.0	0.1	0.1	5.6	2.0	1.4	0.6	0.1	0.2	2.3	1.6	0.0	2.2	0.0	0.1	2.9	0.0	0.1	1.6	0.0	0.6	1.8	1.8	0.0	0.1	2.4	1.6	14.0	0.1	0.0	1.5	0.0	0.0	1.6	1.7	0.2	0.3	1.1	0.4	0.9	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	1.0	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.7	1.1	0.1	0.6	0.0	0.3	1.3	0.0	0.0	0.1	0.3	0.5	0.9	1.2	1.9	1.6	0.0	2.1	0.5	5.2	0.9	0.9	0.0	2.1	0.1	2.4	0.3	0.5	0.2	0.8	0.3	0.2	0.0	0.0	0.3	1.8	0.0	0.3	1.6	0.1	0.6	0.3	2.1	1.7	0.0	0.5	0.8	2.5	0.4	0.0	0.4	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.1	0.1	0.6	0.1	0.6	0.8	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	2.3	0.0	3.6	0.5	0.5	0.3	3.4	0.7	0.5	0.5	0.3	2.8	0.8	3.7	18.8	0.6	0.5	1.0	0.0	0.2	0.1	1.6	1.3	0.6	1.2	8.0	0.0	0.2	0.4	0.9	10.7	2.8	3.8	3.1	0.4	0.3	0.5	0.0	0.0	1.2	0.0	0.8	1.3	0.5	1.2	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.5	0.7	10.7	0.5	2.0	0.8	0.9	7.3	0.0	1.0	1.4	10.9	8.3	6.2	0.4	0.5	2.5	0.9	1.9	0.4
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029714-119033730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	9.5	11.3	7.4	0.3	7.3	0.2	8.3	7.4	7.7	1.9	5.0	2.9	0.3	2.1	1.7	1.0	1.0	0.2	10.3	5.9	11.8	4.6	0.3	1.1	0.4	8.8	8.9	0.3	2.2	0.3	2.8	6.3	8.5	1.0	0.4	4.1	1.3	0.9	38.6	1.6	0.9	1.8	7.1	0.3	3.4	1.9	9.2	0.3	7.1	1.7	0.3	3.3	1.0	10.9	16.4	1.3	2.2	0.4	7.4	1.1	9.7	0.4	0.5	0.4	0.2	2.0	5.6	8.7	2.2	0.1	0.0	5.8	2.7	2.9	0.7	2.6	6.6	0.2	3.8	1.8	3.5	1.0	0.0	1.5	11.7	0.1	1.6	2.4	0.4	3.0	1.7	1.0	0.5	2.3	2.2	2.8	7.1	3.4	1.3	0.0	2.7	5.9	3.1	1.3	6.3	80.4	4.7	46.7	37.4	12.2	7.4	4.7	0.5	0.0	3.4	0.1	0.8	2.4	8.6	3.2	0.7	2.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	7.3	7.4	7.7	5.9	11.8	8.8	8.9	8.5	7.1	9.2	10.9	5.7	6.4	1.1	2.0	1.3	0.8	5.0	1.3	0.6	4.1	10.2	6.1	11.3	1.5	1.2	1.8	10.4	6.5	6.3	4.4	0.0	0.6	0.2	3.9	2.8	1.7	3.0	0.0	0.5	0.2	0.4	4.0	1.1	3.7	0.0	2.6	0.7	0.1	0.7	1.7	2.3	3.8	0.0	0.0	2.1	0.1	1.8	0.9	0.0	0.0	0.0	14.7	1.0	2.0	0.2	0.3	0.1	0.7	1.6	2.9	0.2	0.5	1.2	2.1	0.0	7.7	3.9	0.4	1.0	0.8	1.3	1.0	2.9	0.7	2.1	1.3
NLRP7	"CLR19.4, NALP7, NOD12, PAN7, PYPAF3"	ENSG00000167634	"NLR family pyrin domain containing 7"	Q8WX94	19	54923509-54966312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	30	"testis cancer: 146.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0"									HPA051382	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA051382: AB_2681461"	"unprognostic (2.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.25e-8)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	8.2	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.9	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.6	0.0	0.0	1.9	0.3	0.0	0.0	0.6
NOBOX	"OG2, Og2x"	ENSG00000106410	"NOBOX oogenesis homeobox"	O60393	7	144397240-144410227	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																								"unprognostic (7.88e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309390	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 32.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 62.5;RT4: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.2	32.7	1.4	0.0	1.3	0.0	0.2	1.0	1.5	2.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	1.4	1.3	3.6	2.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.7	19.3	5.9	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	62.5	0.0	0.0	2.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.0	1.5	1.3	1.8	1.4	1.3	1.3	1.2	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	8.2	0.0	0.0	1.9	1.2	0.1	1.8	0.0	2.6	0.0	0.0	10.6	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.0	0.1	0.0	0.0	4.9	0.0	0.1
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"			"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128841-94181968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	11.4	7.2	5.1	12.1	5.2	4.1	6.4	1.2	5.5	7.9	2.7	8.4	5.4	8.5	5.2	7.9	5.2	11.5	9.9	5.0	7.1	6.9	16.8	10.2	6.4	2.1	2.9	7.1	7.4	4.4	4.7	9.7	3.3	7.7	7.2	3.1	6.0	7.0	20.8	8.3	5.8	12.8	2.8	5.8	7.4	9.9	4.9	8.1	8.7	10.8	7.0	21.9	6.5	2.7	24.6	10.2	26.2	16.0	23.9	32.3	17.1	29.8	63.0	25.1	30.7	26.2	37.6	7.8	27.3	30.5	46.1	50.5	20.9	49.2	25.2	33.6	10.9	36.0	10.2	13.5	23.1	18.7	31.0	25.7	33.9	32.8	29.2	16.1	21.2	20.1	23.8	27.5	28.3	7.8	31.3	4.4	21.0	19.7	18.2	36.7	35.0	9.7	16.3	24.0	11.0	31.9	20.9	11.9	14.4	13.3	25.2	9.5	15.4	49.5	25.5	16.4	29.9	4.5	18.2	12.6	20.6	19.0	32.2	3.2	4.0	0.3	2.1	2.2	2.4	1.3	1.7	2.3	2.7	1.2	1.6	1.7	0.2	2.6	1.4	0.4	2.9	3.2	5.1	5.2	1.2	5.5	5.0	7.1	2.1	2.9	3.3	2.8	4.9	2.7	3.8	0.0	8.7	4.6	6.6	102.0	12.3	14.9	13.6	1.3	4.5	2.0	4.7	4.3	4.7	1.8	0.0	12.8	5.3	4.7	0.0	15.7	5.3	9.1	13.0	6.8	2.4	5.2	8.9	18.2	32.4	17.5	7.1	13.9	9.5	4.0	2.2	8.1	20.5	0.0	15.4	4.1	0.0	3.1	21.6	3.9	4.4	11.5	17.8	8.4	3.7	1.1	1.0	9.5	5.8	26.1	3.4	3.8	7.4	10.2	2.6	2.1	6.2	1.1	0.0	16.9	10.6	1.7	8.2	8.3	72.2	23.8	6.6	10.1	4.2	12.7
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.7;lymphoid tissue: 17.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 21.6"	"Cell line enriched"	"Detected in some"	28	"U-266/70: 124.9"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"	0.9	1.1	0.8	7.7	1.1	7.7	1.3	0.6	0.8	0.3	1.5	2.1	2.4	1.1	1.7	0.6	1.4	2.3	0.7	0.7	0.8	0.5	1.7	3.9	17.2	1.8	1.1	0.9	0.6	0.4	0.2	1.0	1.1	0.8	2.5	0.1	2.5	0.6	0.3	2.7	3.2	0.8	0.9	13.9	3.2	0.5	1.2	3.6	0.7	0.0	10.8	2.1	0.2	1.4	0.2	0.0	0.0	0.1	0.0	1.1	2.8	0.1	0.4	0.9	0.9	0.6	1.2	0.9	0.1	0.3	1.8	1.3	0.1	0.2	0.5	2.1	0.0	1.2	0.0	0.1	0.5	0.5	0.7	1.2	0.1	0.5	0.3	0.2	0.0	1.4	0.2	4.5	0.3	0.3	0.1	1.4	0.4	0.1	0.1	1.8	0.0	0.5	0.1	0.4	0.1	0.0	0.0	1.3	0.1	0.2	0.1	0.9	0.6	0.3	0.0	0.8	0.0	124.9	4.3	0.4	1.2	3.1	0.4	1.5	0.3	2.6	21.6	0.7	3.2	3.3	6.0	17.7	0.7	3.5	3.6	12.8	1.6	2.7	0.5	0.6	0.9	3.7	0.8	1.1	0.6	0.8	0.7	0.8	1.8	1.1	1.1	0.9	1.2	1.4	1.4	3.2	1.7	1.6	29.2	0.9	0.6	0.5	0.6	0.0	0.6	0.6	11.7	0.0	0.4	0.0	0.0	0.2	19.1	2.0	0.0	0.4	0.3	2.4	1.0	1.8	0.0	3.0	0.3	0.6	0.5	1.9	8.2	0.8	0.0	1.2	1.4	1.0	2.0	0.0	0.4	1.4	0.0	4.8	2.3	0.0	0.3	5.6	0.0	3.7	5.2	0.0	51.5	0.5	1.3	0.4	0.3	0.0	15.7	0.6	2.2	0.4	8.5	0.0	0.0	1.0	2.6	0.1	0.4	1.4	0.9	0.3	29.8	1.8	0.9	1.3
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 42.3"	"Group enriched"	"Detected in some"	47	"Early spermatids: 647.0;Late spermatids: 316.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"amygdala: 3.1"	"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.4	42.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	647.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	316.3	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 115.6;Late spermatids: 259.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons: 13.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.0;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA056716, HPA075825"	Approved		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA056716: AB_2683215, HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.7	2.2	0.4	1.3	0.9	4.5	1.5	2.5	0.8	1.8	0.5	3.2	2.9	1.7	13.5	2.9	2.0	0.9	3.3	0.8	1.9	3.0	3.1	1.6	2.0	3.5	3.9	2.6	6.5	1.2	2.7	0.6	13.3	3.6	3.3	3.5	1.7	0.3	0.6	4.4	3.9	0.3	1.9	4.7	2.6	20.9	1.0	2.4	2.1	0.0	0.5	1.8	1.9	1.4	0.2	0.4	2.8	2.8	0.0	0.6	1.9	0.6	0.2	0.6	2.1	1.1	2.8	1.9	0.4	0.1	0.1	1.8	1.0	0.1	1.4	0.2	4.3	1.9	3.7	3.1	0.0	4.2	3.2	0.0	0.9	0.1	2.1	0.6	0.8	2.3	0.4	1.7	0.1	2.4	1.1	6.8	0.8	0.1	1.2	2.9	0.2	1.5	0.3	0.8	21.0	10.7	0.0	0.0	0.2	2.0	0.5	2.7	1.8	1.3	2.2	0.6	1.4	3.9	1.5	1.2	0.6	2.8	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.9	2.5	0.8	0.8	1.9	3.5	3.9	13.3	1.9	1.0	1.4	0.0	0.0	0.6	1.0	0.3	0.4	0.1	0.1	1.2	0.9	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.0	0.2	115.6	0.3	0.2	0.3	5.4	0.8	0.7	0.2	0.1	0.6	0.0	0.1	3.8	0.3	0.0	0.1	4.7	30.3	0.7	0.7	0.0	1.9	5.5	259.5	1.2	2.4	0.0	1.0	0.0	1.1	0.0	1.0	1.6	0.1	0.1	1.5	0.0	0.1	0.2	0.6	1.6	0.2	0.0	0.0	0.1	2.9	0.9	0.3	0.0	0.1	1.0	0.0	0.9	0.2
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572310-42577831	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 113.3;Spermatogonia: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA044439	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	3.3	1.4	8.3	2.5	8.9	8.2	3.8	8.7	10.3	3.5	7.9	4.2	1.3	3.7	3.8	3.0	6.2	1.4	1.8	7.8	8.5	2.8	0.8	2.3	3.9	9.4	8.9	3.4	2.1	7.6	1.5	4.2	9.2	3.6	3.0	7.3	1.5	3.9	1.5	3.1	1.6	5.2	9.0	1.9	2.4	23.7	8.8	7.4	1.8	2.3	5.5	2.9	2.9	8.9	21.1	29.0	48.3	34.9	11.0	15.0	11.0	80.4	23.7	63.4	78.3	28.6	12.9	21.1	17.6	22.2	27.6	29.9	36.9	28.8	73.0	31.0	30.0	13.5	66.1	35.0	1.6	46.3	14.4	5.3	6.4	101.5	34.2	9.4	18.8	28.3	44.5	38.2	56.6	21.8	33.3	28.0	30.0	23.9	26.8	32.3	50.7	20.6	14.8	16.6	65.1	40.6	32.1	11.8	34.7	24.3	28.3	20.3	8.8	70.5	41.1	55.2	128.6	30.0	54.1	30.8	32.8	21.2	79.7	0.0	0.0	0.9	0.7	0.2	0.9	1.1	0.4	0.7	0.0	0.3	0.1	0.4	0.9	0.1	0.3	2.8	0.7	0.1	8.3	8.9	8.7	10.3	7.8	8.5	9.4	8.9	9.2	9.0	8.8	8.9	6.0	3.2	3.7	2.3	6.4	5.4	2.7	3.7	0.0	5.9	4.8	5.2	0.9	4.3	2.8	3.7	10.4	15.6	3.7	1.4	0.0	4.5	12.8	11.1	5.8	4.4	0.0	19.8	1.1	3.3	19.1	5.5	1.5	5.0	1.3	7.7	2.9	2.2	7.4	0.0	1.2	1.2	4.1	3.0	2.6	13.1	5.3	2.4	5.4	2.8	5.8	4.6	3.1	1.0	1.5	2.0	0.3	8.6	6.5	2.0	0.2	2.2	14.9	13.9	19.7	8.6	16.0	113.3	44.6	3.2	4.1	5.2	2.7	2.5	2.5	1.7
QRICH2	DKFZP434P0316	ENSG00000129646	"Glutamine rich 2"	Q9H0J4	17	76274049-76307998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.8;Excitatory neurons: 9.8;Inhibitory neurons: 14.5;Late spermatids: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052219	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA052219: AB_2681766"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.82e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-3)"	1.0	0.7	3.9	0.7	3.7	1.7	1.1	6.3	7.0	1.8	2.5	1.6	0.3	1.1	0.7	2.1	1.6	0.3	1.6	3.6	3.6	2.0	2.3	1.7	0.6	6.3	3.8	1.3	1.9	0.6	1.8	1.0	6.4	2.1	0.6	2.7	3.6	0.5	1.2	1.3	1.1	0.4	3.2	1.1	1.2	18.3	4.5	0.5	4.4	0.5	0.5	1.0	1.7	4.4	0.8	1.6	2.9	3.3	1.5	1.4	1.4	1.4	0.3	1.0	0.3	0.5	0.3	4.2	0.5	0.9	0.8	0.3	4.0	0.7	1.3	1.1	2.2	0.4	1.2	3.7	0.8	0.6	1.9	1.3	0.6	1.2	0.1	2.0	1.3	1.2	2.3	0.8	0.3	2.5	2.3	0.5	1.2	1.0	3.2	4.9	2.5	0.1	0.5	1.5	2.7	2.7	0.7	0.4	1.7	2.9	1.2	1.7	1.2	0.8	3.1	4.1	1.7	1.1	1.1	0.4	0.9	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.7	6.3	7.0	3.6	3.6	6.3	3.8	6.4	3.2	4.5	4.4	0.8	0.0	0.0	6.5	0.8	0.1	0.4	0.2	0.0	0.7	1.5	1.8	1.7	5.7	0.3	1.8	0.0	0.7	0.1	0.7	0.0	0.9	33.8	1.4	0.9	0.9	0.0	0.4	9.8	0.0	1.1	0.3	2.0	1.6	0.0	3.7	0.0	0.5	0.2	1.7	14.5	0.5	0.0	0.6	0.4	9.1	0.9	0.3	1.8	5.6	0.6	1.9	1.0	5.5	5.4	0.4	0.2	0.7	0.9	0.3	0.2	0.8	1.1	2.3	0.0	0.9	1.0	5.0	1.5	0.6	0.3	0.4	0.4	0.1	0.6	0.3
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634892	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 28.9;endometrium 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 7.7;Breast myoepithelial cells: 15.6;Fibroblasts: 5.4;Langerhans cells: 2.9"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;THP-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	11.3	0.1	0.0	0.8	0.1	0.1	7.9	0.1	0.1	28.9	0.0	1.8	1.1	41.4	2.2	3.1	20.0	2.7	0.7	0.1	0.0	0.8	0.1	4.0	1.9	0.1	0.1	2.1	0.5	0.1	0.1	0.4	0.1	6.7	0.5	0.1	1.3	1.8	0.0	6.6	3.3	13.1	0.0	0.8	4.0	0.2	0.1	0.0	0.0	0.5	3.0	1.5	19.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	15.6	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1
SEPTIN12	"FLJ25410, SEPT12"	ENSG00000140623	"Septin 12"	Q8IYM1	16	4777606-4788398	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"testis: 98.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041128			Uncertain	Microtubules		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Microtubules		"HPA041128: AB_10796568"	"unprognostic (2.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.45e-2)"		"unprognostic (7.40e-2)"		"unprognostic (1.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-8)"	"unprognostic (7.41e-2)"	"unprognostic (9.87e-2)"		"unprognostic (8.36e-3)"	0.0	0.0	0.1	0.0	0.3	0.1	0.1	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	98.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.5	0.3	0.1	0.4	0.1	0.4	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.2	0.1	0.6	0.3	0.5	4.8	0.1	0.8	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.1	0.0	0.1	0.3	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.8	0.8	0.4	1.1	0.9	0.6	1.1	0.3	0.9	0.2	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.9;choroid plexus: 13.1;testis: 16.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	15.5	0.0	17.0	0.0	0.0	13.9	28.9	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.3	13.7	0.0	0.0	0.0	0.0	17.8	13.7	0.1	0.0	0.1	3.2	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.5	0.1	0.1	16.9	13.5	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	17.0	13.9	28.9	16.3	13.7	17.8	13.7	17.8	13.5	13.5	19.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SOX3	PHP	ENSG00000134595	"SRY-box transcription factor 3"	P41225	X	140502985-140505069	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;fallopian tube: 9.2;testis: 2.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 2.9;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 2.0;Skeletal myocytes: 3.1;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HEK 293: 8.1;NTERA-2: 17.9;SuSa: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.0	0.1	1.0	0.0	1.2	0.0	0.0	0.8	1.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.7	4.9	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	2.3	3.7	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.0	0.7	4.9	1.2	1.2	0.9	1.1	3.7	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	7.3	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SPATA16	NYD-SP12	ENSG00000144962	"Spermatogenesis associated 16"	Q9BXB7	3	172889357-173141235	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	595	"testis: 59.5"	"Group enriched"	"Detected in some"	49	"Early spermatids: 288.6;Late spermatids: 129.3;Spermatocytes: 192.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037884	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA037884: AB_2675717"															"unprognostic (3.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.6	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	129.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	192.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5310.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.1	1.1	0.2	13.5	1.3	0.1	0.6	1.3	1.8	2.8	1.9	0.3	5310.4	0.2	0.3	0.1	7.4	0.2	0.2	0.3	0.2	0.2	4.7	0.3	0.3	0.4	0.1	0.0	4.2	0.0	0.2	3.5	2.1	0.0	2.0	240.7	1.8	0.5	3.1	0.3	0.2	1.7	3.0	346.1	0.3	3.9	0.6	2.3	4.8	0.5	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.1	0.2	0.1	0.6	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.1	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.5;fallopian tube: 20.4;liver: 60.8;prostate: 16.8;seminal vesicle: 18.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Region enriched"	"Detected in single"	11	"midbrain: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	23.5	0.0	20.4	0.0	0.0	0.0	0.0	0.3	60.8	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.1	0.0	18.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787682	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.8;testis: 2.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Muller glia cells: 2.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"								"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.7;HMC-1: 54.4;U-698: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.2	0.2	0.1	0.1	0.1	0.8	0.3	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.1	54.7	0.3	0.6	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	41.7	1.1	0.0	0.1	0.2	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.4	0.0	0.1	0.8	0.2	0.0	0.3	1.4	0.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.3	1.9	0.0	2.7	2.9	56.5	6.8	10.9	1.8	1.2	7.4	1.9	1.8	2.2	10.0	1.7	7.3	2.1	2.0	12.1	1.7	13.7	0.3	29.8	26.1	2.9	4.2	1.2	8.4	6.5	0.2	3.3	4.1	0.5	7.8	1.3	4.9	4.2	29.4	2.2	20.2	6.1	5.7	0.0	2.2	8.6	23.5	4.7	4.6	5.4	5.6	4.2	2.7	13.4	5.0	5.1	0.2	0.5	1.9	2.1	8.2	1.1	6.9	15.1	7.0	0.0	8.0	5.4	152.6	60.0	0.4	8.5	2.9	10.8	2.6	2.0	11.7
SUN5	"dJ726C3.1, SPAG4L, TSARG4"	ENSG00000167098	"Sad1 and UNC84 domain containing 5"	Q8TC36	20	32983773-33004433	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	449	"testis: 44.8"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 510.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048529	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA048529: AB_2680428"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	510.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYCP3		ENSG00000139351	"Synaptonemal complex protein 3"	Q8IZU3	12	101728648-101739472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 82.9"	"Group enriched"	"Detected in many"	8	"Spermatocytes: 825.7;Spermatogonia: 346.9"	"Cancer enriched"	"Detected in single"	16	"testis cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB032978, HPA039635, HPA043938"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740"	"unprognostic (2.86e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.61e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.15e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.86e-4)"	0.0	0.1	0.3	0.3	0.4	0.2	0.0	0.5	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	82.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.4	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	2.0	9.1	4.5	0.0	0.7	0.4	1.2	2.2	0.9	0.6	1.3	1.5	0.3	1.8	0.0	0.4	3.1	0.6	0.0	0.1	24.1	0.3	1.3	0.9	1.2	0.4	10.1	0.4	0.2	0.7	0.0	0.7	3.8	0.3	0.7	0.2	0.6	0.0	10.7	0.7	0.0	1.0	0.3	31.2	9.0	1.7	0.0	0.0	0.4	0.3	1.0	9.5	1.8	0.3	1.9	1.9	2.0	0.9	1.0	0.3	0.8	1.7	65.7	2.0	0.4	825.7	346.9	0.7	0.3	0.1	2.0	0.2	1.3	0.5
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26226445-26391685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 65.0;U-266/70: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	1.5	2.0	0.4	2.8	0.4	2.8	2.7	0.3	1.9	1.2	0.0	1.6	0.4	1.4	0.3	1.0	1.3	0.7	0.4	0.3	0.2	1.5	0.1	1.0	3.1	0.9	0.1	3.1	1.2	0.6	0.2	1.7	1.1	0.8	1.4	0.3	1.1	0.8	1.3	1.5	0.8	1.2	0.0	2.5	1.8	4.6	0.2	1.8	1.7	0.7	3.2	1.5	0.6	0.8	4.3	0.7	0.3	1.1	1.6	2.6	2.1	1.3	1.5	0.7	1.3	1.1	2.3	65.0	5.0	0.3	2.5	4.8	3.7	4.0	3.4	15.5	9.9	7.5	1.9	1.0	2.3	20.5	4.4	4.3	1.5	0.5	11.6	0.6	1.4	8.1	10.2	7.9	0.3	4.2	10.7	4.1	3.5	2.5	5.1	0.0	8.1	17.3	1.0	0.3	6.1	2.8	3.9	5.7	2.7	1.6	2.0	3.6	0.9	2.7	1.6	3.7	4.8	26.2	18.0	21.8	1.3	12.8	2.4	0.0	0.3	0.0	0.1	0.5	1.0	2.3	0.7	1.0	1.0	2.0	2.0	1.6	0.0	0.6	0.2	0.3	0.1	0.6	0.4	0.4	0.3	1.9	0.3	0.2	0.9	0.1	1.1	0.0	0.2	0.8	7.2	6.4	7.2	6.2	34.0	80.3	9.5	1.7	49.5	1.5	15.0	17.9	2.8	0.0	2.5	0.0	0.0	18.6	4.1	5.8	17.6	1.2	0.7	28.9	9.7	9.0	0.0	21.7	44.8	2.0	4.3	15.5	36.7	45.0	1.3	5.4	1.1	0.0	2.4	5.0	28.3	7.0	2.0	1.6	17.9	1.6	3.4	5.9	23.2	4.7	2.6	0.2	1.0	7.5	11.7	2.2	2.5	4.1	52.3	13.9	0.8	4.0	1.0	1.2	0.0	17.6	12.1	25.4	24.8	40.8	78.8	9.7	14.5	14.5	6.2	6.7
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928456-104052667	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 30.6;testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.5	0.9	0.6	0.8	1.7	0.5	1.3	0.9	0.4	1.2	0.3	0.1	0.4	0.4	0.2	0.9	0.9	0.6	0.8	0.8	2.1	0.3	1.0	0.5	1.7	1.0	0.2	0.5	30.6	1.0	0.5	2.0	0.3	0.2	3.5	0.3	0.5	0.1	0.1	0.3	0.5	1.1	3.0	0.8	40.7	1.1	0.3	5.4	0.5	0.5	0.4	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	21.5	0.0	0.0	0.0	94.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	8.7	0.0	0.0	0.6	13.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.8	1.3	0.9	0.8	0.8	1.7	1.0	2.0	1.1	1.1	1.3	0.9	6.4	2.0	2.3	0.0	0.0	0.1	0.1	0.0	4.3	1.0	0.4	12.4	0.0	0.7	0.0	4.2	0.0	0.5	0.0	1.9	0.6	13.1	43.2	1.5	0.9	0.0	1.3	9.1	0.0	0.0	0.7	0.0	3.7	0.0	0.3	0.4	0.1	1.9	6.7	4.6	0.0	2.0	1.8	0.0	7.3	0.9	1.5	0.0	2.8	2.9	0.6	0.0	1.0	4.6	0.5	0.0	2.2	0.3	0.5	0.0	2.5	0.2	2.3	6.6	0.9	0.8	63.2	38.6	0.0	0.0	0.0	0.3	11.7	0.0	0.1
TEX11	"MZIP4, Spo22, TGC1, TSGA3, ZIP4"	ENSG00000120498	"Testis expressed 11"	Q8IYF3	X	70528940-70908711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 58.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 20.1;Early spermatids: 14.7;Exocrine glandular cells: 9.7;Late spermatids: 28.0;Paneth cells: 12.5;Spermatocytes: 46.5;Spermatogonia: 30.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3;testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002950	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA002950: AB_1080249"	"unprognostic (6.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.87e-3)"	"unprognostic (7.77e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	3.9	1.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	58.8	0.0	0.0	0.2	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.5	11.6	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	14.7	0.1	0.0	0.2	1.2	0.0	2.6	9.7	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.8	0.0	0.0	0.3	28.0	0.6	0.1	0.0	0.0	0.6	0.0	0.0	2.0	1.9	0.5	12.5	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	46.5	30.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TLE6	"FLJ14009, GRG6"	ENSG00000104953	"TLE family member 6, subcortical maternal complex member"	Q9H808	19	2977538-2995179	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 7.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 8.6;Collecting duct cells: 12.9;Distal tubular cells: 7.9;Extravillous trophoblasts: 10.1;Syncytiotrophoblasts: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.6;SK-BR-3: 14.0;U-266/70: 14.5;U-698: 16.5;U-937: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (1.32e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.63e-5)"	"unprognostic (4.05e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-4)"	"unprognostic (3.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-3)"	0.8	1.1	0.7	0.2	0.6	0.0	1.8	1.7	0.8	1.1	0.3	1.2	0.6	1.6	2.7	0.6	0.9	0.2	1.1	0.4	2.0	3.3	3.8	2.3	0.8	0.9	1.0	0.4	1.8	2.6	1.7	4.9	0.8	1.3	1.3	1.9	3.3	3.2	0.3	0.7	0.4	0.8	0.7	1.2	1.0	3.3	2.9	1.1	7.3	0.1	0.5	1.0	0.6	0.9	4.7	6.1	0.1	2.6	0.1	0.0	18.6	0.0	0.1	0.4	1.0	0.0	1.4	8.6	1.4	0.5	1.5	0.1	2.3	1.3	0.3	7.2	1.1	0.0	0.2	0.7	0.7	0.2	1.5	1.1	0.9	0.0	0.2	1.4	1.1	6.3	1.5	0.1	0.5	3.1	0.0	0.4	0.0	9.1	1.2	5.0	0.4	7.2	1.7	1.1	0.4	1.7	0.4	14.0	5.6	0.5	3.7	0.8	1.0	0.6	0.8	0.4	0.4	14.5	10.6	16.5	3.4	12.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.5	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.1	0.7	0.6	1.7	0.8	0.4	2.0	0.9	1.0	0.8	0.7	2.9	0.9	0.5	0.0	8.6	0.0	0.8	0.1	1.9	1.3	1.8	3.1	4.0	3.7	1.6	4.3	1.6	12.9	0.0	6.1	0.2	2.4	7.9	1.7	0.8	1.0	0.6	0.7	3.6	0.0	0.5	1.0	10.1	0.7	1.5	2.6	0.0	0.2	0.4	3.1	1.4	0.0	0.9	2.4	2.0	0.3	0.4	2.9	0.3	0.3	5.4	0.0	0.0	6.9	0.0	0.0	0.5	1.0	0.6	0.4	0.2	0.6	0.1	0.7	0.1	0.9	0.0	0.0	0.5	0.2	4.8	0.7	0.0	8.6	0.2	0.5	1.5	0.9
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892884-919357	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 115.4;Late spermatids: 206.9;Respiratory ciliated cells: 79.9;Spermatocytes: 86.4;Spermatogonia: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.4	0.7	2.0	4.4	2.1	6.0	2.7	0.9	1.8	1.5	1.0	3.8	3.5	1.8	0.6	4.6	6.7	0.7	0.4	1.6	1.5	1.1	0.8	1.3	7.1	1.3	2.0	2.0	1.3	0.2	1.6	3.3	1.4	0.8	5.7	0.5	1.0	0.4	0.6	2.3	3.6	3.5	1.1	1.9	1.7	29.9	1.9	9.3	0.5	0.3	8.4	1.9	1.7	1.2	67.5	73.9	46.6	69.6	4.3	10.1	51.8	68.6	33.1	103.4	96.7	72.2	43.4	59.1	48.7	39.5	90.1	48.7	100.3	47.6	129.1	91.0	83.7	40.6	136.4	52.3	1.1	67.3	23.9	4.7	3.6	87.0	37.3	10.7	51.5	45.9	61.7	50.2	71.7	45.7	67.6	60.6	53.0	37.7	69.4	38.8	87.3	113.0	29.3	34.2	47.9	49.0	103.1	38.2	20.8	40.2	71.3	32.0	26.4	55.6	70.4	46.5	79.0	31.9	68.9	64.6	34.2	79.3	63.1	0.0	0.0	0.0	0.4	0.0	0.2	1.1	0.6	0.7	0.1	1.2	0.2	0.1	0.0	1.6	0.1	1.0	2.1	0.4	2.0	2.1	0.9	1.8	1.6	1.5	1.3	2.0	1.4	1.1	1.9	1.2	0.7	0.0	1.1	0.3	4.3	3.4	3.5	7.3	4.0	0.9	2.2	1.8	0.3	0.0	5.0	0.0	0.0	8.6	0.7	2.2	0.0	3.0	115.4	29.3	2.1	2.5	4.2	14.3	1.3	2.0	25.2	3.4	1.5	3.8	5.7	9.8	2.2	0.4	7.3	3.3	0.5	3.0	4.1	1.3	4.2	206.9	2.1	1.7	0.0	0.0	1.1	0.7	0.0	0.0	0.4	2.2	1.8	2.2	18.1	2.8	0.5	1.2	79.9	0.9	6.6	2.5	5.2	86.4	70.1	7.6	1.4	3.4	3.2	2.7	5.1	3.3
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 51.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	1.1	1.0	1.8	0.6	1.6	0.7	1.4	1.6	1.9	1.3	3.7	0.9	1.0	1.1	1.6	0.6	12.6	1.1	0.2	1.8	1.6	3.0	0.5	1.6	1.0	3.4	3.5	0.5	1.7	1.6	2.5	0.4	2.5	1.0	1.3	2.6	1.1	0.6	0.1	1.9	0.6	0.3	2.7	0.8	1.4	51.5	1.5	1.1	3.1	0.2	0.8	0.6	0.4	3.7	0.8	0.2	1.2	0.5	0.6	0.7	0.9	0.0	0.1	0.3	0.2	0.2	0.8	0.7	0.2	0.0	0.5	0.2	0.2	0.2	0.3	1.0	0.8	0.1	0.0	0.3	0.0	0.5	1.7	0.9	1.0	0.1	0.1	0.7	0.0	0.9	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.2	0.3	0.1	0.2	4.2	0.7	1.7	0.2	0.9	0.7	0.2	1.3	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.6	0.3	0.3	0.3	1.0	0.4	0.1	0.2	0.2	0.6	0.0	0.7	0.7	0.7	0.8	0.0	0.8	1.1	0.7	0.0	1.0	0.0	0.4	0.7	0.3	1.8	1.6	1.6	1.9	1.8	1.6	3.4	3.5	2.5	2.7	1.5	3.7	3.1	3.2	9.2	35.3	13.3	3.6	10.3	8.6	6.2	19.3	13.9	15.4	7.1	17.2	14.5	23.9	29.2	9.7	5.6	4.7	25.4	8.4	458.9	80.6	4.5	4.0	15.5	8.6	73.4	10.5	4.3	5.8	8.6	10.9	5.1	5.3	4.2	7.1	4.6	20.2	57.9	6.7	12.2	3.1	1.4	294.2	11.1	5.1	1.8	23.4	4.5	21.1	15.5	27.6	144.9	4.7	12.2	9.8	8.1	7.8	8.0	12.9	107.9	36.6	6.6	5.7	6.2	206.8	36.6	5.6	4.4	9.3	8.9	5.9	8.4	7.9
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035510: AB_2674659, HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.1	0.1	0.6	0.4	0.6	0.1	0.2	0.4	1.1	0.2	1.8	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.1	0.5	0.6	0.1	0.1	0.2	0.3	0.7	0.9	0.3	1.1	0.2	0.1	0.1	0.6	0.2	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.0	0.5	0.2	0.1	21.2	0.5	0.2	0.2	0.1	0.3	0.1	0.1	0.6	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.3	0.2	0.2	0.2	0.0	0.4	0.2	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.8	0.3	0.0	0.8	0.0	0.2	0.0	0.1	0.7	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.1	0.5	0.6	0.7	0.9	0.6	0.5	0.5	0.6	3.7	0.0	3.0	20.2	10.4	0.6	4.4	4.0	0.6	5.3	2.6	2.4	6.4	4.3	5.4	1.8	8.4	1.7	1.8	2.5	0.0	2.1	82.3	24.0	3.6	3.0	4.2	0.4	15.0	1.8	1.7	2.1	4.1	5.2	1.3	3.2	5.0	1.3	1.6	5.0	13.3	2.5	0.0	2.2	0.9	84.7	7.2	1.6	3.6	4.7	2.6	3.4	0.0	5.0	3.2	1.7	2.0	6.0	3.7	2.1	2.3	1.2	56.0	15.3	6.6	7.8	2.7	59.8	3.4	0.1	0.6	3.7	1.3	2.1	2.4	2.3
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
USP9Y	"AZFA, DFFRY"	ENSG00000114374	"Ubiquitin specific peptidase 9 Y-linked"	O00507	Y	12537650-12860839	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 21.5;RT4: 17.4"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	3.6	5.2	1.3	1.7	1.4	2.6	3.3	2.8	5.2	0.0	2.5	4.5	1.7	0.0	7.2	5.2	0.0	4.6	5.5	1.3	1.4	7.1	3.0	5.2	2.2	1.2	1.1	0.0	6.0	3.5	8.8	2.3	1.3	9.7	4.9	12.9	4.9	7.0	5.2	3.2	4.4	0.0	1.0	5.1	3.9	4.2	1.4	0.0	5.7	9.7	5.6	4.5	0.0	2.4	0.0	4.7	0.0	0.0	0.0	0.0	5.3	14.2	14.6	7.2	8.5	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	8.6	8.1	0.0	7.3	0.0	9.5	5.8	0.0	0.0	9.7	8.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	12.2	0.0	9.8	0.0	4.6	0.0	0.0	0.0	3.5	2.1	21.5	17.4	7.2	0.0	0.0	0.0	4.4	12.5	0.0	0.2	10.6	9.5	0.0	0.0	7.0	0.0	9.7	15.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.4	0.7	0.5	0.1	0.7	0.8	0.5	0.0	0.1	0.0	0.6	0.6	0.0	1.3	1.4	2.8	5.2	1.3	1.4	1.2	1.1	1.3	1.0	1.4	2.4	0.0	25.6	23.5	29.4	11.0	11.7	8.5	9.5	18.2	23.6	0.0	0.0	26.5	7.2	12.6	20.2	64.6	6.3	5.3	0.3	1.9	6.9	0.5	0.0	0.0	5.8	0.0	5.9	89.5	0.0	1.7	8.1	6.6	0.0	2.5	0.0	6.1	2.3	3.1	26.9	69.5	1.1	8.2	5.6	9.3	1.1	12.5	3.6	3.6	31.9	3.6	8.8	14.4	28.6	17.4	2.3	0.0	15.4	4.1	13.2	0.7	6.3	19.9	23.1	0.0	5.2	4.4	2.8	2.6	20.6	11.6	3.4	14.7	0.0	1.5	11.9
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117313-22143969	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 42.1;Breast glandular cells: 19.9;Breast myoepithelial cells: 24.3;Endometrial stromal cells: 71.4;Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;SCLC-21H: 10.2;SK-BR-3: 8.6;T-47d: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.8	9.0	2.4	0.4	1.5	0.3	2.2	0.2	2.9	8.9	0.5	2.3	3.2	4.5	8.9	12.1	8.3	2.6	0.1	2.0	2.9	1.1	1.4	1.2	0.1	1.6	1.8	16.8	3.0	0.1	5.6	1.6	1.2	5.5	1.6	0.2	4.1	2.6	3.1	40.8	3.1	1.9	1.1	0.3	4.3	0.6	3.9	1.1	3.4	0.6	1.5	3.1	6.3	1.1	1.3	0.1	2.5	0.1	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.3	8.5	0.0	0.6	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	1.1	0.2	0.3	0.0	0.0	0.0	1.6	10.2	0.0	0.1	8.6	0.6	0.6	3.4	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.5	0.2	2.9	2.0	2.9	1.6	1.8	1.2	1.1	3.9	1.1	0.9	3.2	8.6	0.3	0.7	16.7	4.3	42.1	6.8	0.0	19.9	24.3	0.6	0.0	15.2	0.0	0.0	0.7	0.1	0.9	0.0	2.7	0.1	4.1	71.4	0.6	29.4	0.0	0.2	0.6	0.1	3.1	0.5	1.6	0.0	0.2	0.7	0.5	0.1	0.0	1.9	16.0	4.1	0.0	0.2	0.9	0.0	0.4	5.4	6.5	0.1	0.0	0.0	0.0	0.3	0.9	0.1	3.8	0.6	5.7	0.3	0.0	12.0	0.0	0.0	0.4	2.2	0.0	0.3	2.5	10.4	0.3	0.6	0.0	0.6	4.2
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	26.5	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	18.4	0.0	0.7	0.0	67.6	5.3	0.0	52.3	1.3	4.5	0.1	0.0	16.3	0.1	0.8	0.0	0.2	0.1	45.8	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.1	0.0	19.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804539	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.2;ovary: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 115.2;Excitatory neurons: 524.4;Inhibitory neurons: 159.8;Microglial cells: 152.7;Oligodendrocyte precursor cells: 689.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 64.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ hTERT+: 14.2;HHSteC: 9.9;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.9;K-562: 6.0;TIME: 6.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 39.4"	HPA004094	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	12.2	2.8	7.4	1.5	3.1	0.0	4.5	64.2	12.7	6.5	0.0	4.3	0.5	10.7	2.3	4.5	12.3	5.8	10.2	16.4	3.5	1.1	2.7	3.8	2.7	11.9	5.7	33.3	0.7	0.4	1.1	4.2	12.3	0.9	2.1	1.1	1.0	1.9	18.0	1.6	1.9	17.8	0.2	2.9	2.8	4.3	6.3	1.3	6.8	17.2	1.5	7.0	4.9	3.4	0.0	0.0	6.4	0.0	5.4	1.7	0.0	0.5	14.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.7	0.0	1.9	10.9	0.0	6.0	0.0	1.3	0.0	1.4	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	4.3	0.0	6.5	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	3.1	64.2	12.7	16.4	3.5	11.9	5.7	12.3	0.2	6.3	3.4	10.0	0.0	0.6	115.2	0.1	3.6	0.3	0.0	0.6	2.9	0.1	0.3	21.3	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	55.2	0.6	9.8	7.9	0.0	0.0	524.4	0.0	0.1	17.1	1.1	1.5	0.0	24.6	7.1	0.0	0.3	8.4	159.8	0.2	0.0	0.0	1.7	34.0	23.9	0.3	1.8	152.7	0.6	0.1	0.0	689.7	10.0	0.1	0.0	13.5	0.0	0.6	0.0	0.0	0.0	0.7	6.6	22.5	8.1	0.9	2.2	0.1	2.8	0.4	0.2	1.4	0.2	0.4
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4739833-4746119	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 28.3"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	1.8	1.3	1.6	2.4	1.6	1.0	1.7	1.6	2.5	0.9	1.7	0.8	4.0	0.6	0.5	0.9	1.1	2.8	0.6	1.6	1.8	1.9	3.1	4.6	1.7	2.4	2.0	0.7	1.2	5.5	1.4	1.2	2.0	1.7	0.7	0.3	3.1	0.8	0.4	1.4	3.0	0.7	2.0	5.5	1.9	28.3	2.4	0.8	1.1	0.1	0.4	1.8	0.7	2.6	2.1	0.3	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.5	1.1	0.9	1.9	0.0	0.0	0.0	0.2	1.6	0.4	0.1	0.0	0.2	0.7	0.0	0.2	0.5	0.3	0.0	0.6	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.6	0.6	0.9	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.6	1.6	1.6	2.5	1.6	1.8	2.4	2.0	2.0	2.0	2.4	2.6	0.8	0.0	2.0	1.3	0.6	0.9	8.0	1.8	0.6	0.3	4.4	3.7	0.7	2.8	3.1	1.8	0.0	0.1	0.2	3.3	0.0	1.6	191.4	2.8	0.3	1.4	1.2	0.0	0.0	3.9	0.0	0.7	4.6	2.7	0.0	0.3	3.9	0.6	5.2	0.0	0.1	2.9	0.0	11.9	7.3	30.9	0.6	12.9	1.8	1.9	21.9	2.0	0.0	1.0	0.5	3.5	1.4	2.2	0.1	6.7	3.8	0.8	3.7	0.3	0.0	0.2	1.0	24.3	2.0	0.5	0.9	0.0	0.2	0.3	1.3	8.5
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Early spermatids: 32.3;Late spermatids: 87.6"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	32	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	32	"dendritic cells: 3.1"	"Group enriched"	"Detected in some"	40	"RPMI-8226: 12.4;SK-BR-3: 3.3"	"Not detected"	"Not detected"												"Secreted in female reproductive system"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.3	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.1	0.7	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	32.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	87.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.1	5.0	1.9	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.1
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 4.8"	"Cell type enriched"	"Detected in single"	15	"Proximal enterocytes: 7.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"cerebellum: 4.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	37	"HDLM-2: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011296	Enhanced				"Secreted in female reproductive system"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
ZP3	"ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC"	ENSG00000188372	"Zona pellucida glycoprotein 3"	P21754	7	76397518-76442071	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 78.4;Early spermatids: 45.6;Late spermatids: 89.7;Spermatocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 35.2;hTCEpi: 37.8;Karpas-707: 52.0;MCF7: 71.6;OE19: 30.2"					"Not detected"	"Not detected"			"HPA054061, HPA071198"	Supported				"Secreted in female reproductive system"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA054061: AB_2682363, HPA071198: "	"unprognostic (6.48e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.13e-1)"	1.0	2.9	1.1	0.7	1.9	2.2	3.1	1.3	1.7	1.1	1.9	2.4	1.9	0.8	2.2	4.2	4.0	0.6	0.3	1.0	1.1	1.0	0.8	0.5	0.8	1.2	1.0	2.8	4.1	0.6	1.2	0.6	1.3	1.4	2.6	0.5	1.5	0.7	1.4	4.1	1.1	1.1	1.0	1.8	1.1	1.3	1.2	0.5	0.8	0.4	0.9	0.7	2.4	1.3	17.6	35.2	0.2	18.4	0.9	1.0	0.9	1.2	2.8	0.3	3.3	1.3	15.2	0.1	0.6	4.6	0.5	4.3	3.8	1.2	0.3	9.5	8.5	2.8	10.5	0.1	8.0	0.7	5.2	1.5	37.8	3.9	1.1	0.1	0.7	9.1	4.0	52.0	0.0	71.6	1.6	9.1	3.8	30.2	10.0	0.1	1.5	3.9	1.6	0.2	7.6	0.0	4.6	23.9	0.6	0.4	15.6	3.0	2.2	0.1	1.8	0.1	0.1	15.4	13.4	0.1	1.5	20.2	3.2	0.6	9.4	0.1	0.1	4.0	0.4	2.4	1.1	0.5	9.6	1.1	4.5	3.2	0.8	0.2	4.5	2.0	0.1	3.1	1.1	1.9	1.3	1.7	1.0	1.1	1.2	1.0	1.3	1.0	1.2	1.3	2.6	3.2	3.6	1.3	2.9	8.5	5.8	78.4	9.6	1.5	9.3	12.6	0.8	4.3	21.1	1.8	0.0	5.8	2.7	5.3	0.0	2.9	45.6	1.6	1.4	2.8	4.2	3.0	3.3	4.3	3.6	1.9	1.1	3.0	0.0	5.0	2.9	0.8	7.0	1.7	2.7	4.7	6.1	7.2	4.6	89.7	4.4	5.7	3.6	2.8	5.4	4.4	0.0	1.5	1.7	3.3	8.6	5.7	4.2	5.5	0.6	3.7	20.4	2.0	6.6	3.1	2.5	34.9	12.4	9.0	9.9	9.3	2.2	2.7	7.6	17.1